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CHAPTER I 
INTRODUCTION 
HERBAL DRUGS: 
Plants are the only economic source of a number of well established and 
important drugs. In addition, they are also the source of chemical intermediates need for 
the production of drugs 
[1]
. 
Inspite of tremendous advances made in the modern system of medicine, there are 
still lack of conditions for which suitable drugs are not available in the allopathic system 
Moreover the modern system of medicine producing lot of side effects to the patients
 [2]
. 
Nowadays herbs have been the main source of medicine throughout the human history. 
About 25-30% of todays prescription drugs contain chemicals derived from herbs
 [3]
. 
The factors responsible for the continued and extensive use of herbal drugs in 
India are their effectiveness, easy availability, low cost, comparatively less toxic effects 
and shortage of practitioners in rural areas. 
Natural products are having complex molecular architecture and they show 
amazing arrangements of functional groups, ring system and other attractive structural 
attributes. The reasons for interest in natural products are 
[4]
 
 Serve as a lead compounds for newer drugs. 
 Give information about the bio mechanism. 
 Natural products are permanent challenge with respect to total synthesis  
   and stimulate the development of new reagents and reactions. 
 Collection of natural products as well as their derivatives and analogues  
are valuable starting points for drug discovery
.[5]
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The main limitation of plant is the lack of standardization of raw materials, 
processing methods, the final products, dosage, formulations and non existence criteria 
for quality control.
 [1]
 
Undoubtfully, the plant kingdoms still hold many species of plants containing 
substance of medicinal value which have yet to be discovered and large numbers of 
plants are constantly being screening for their pharmacological value. So that we have to 
made an attempt to identify the medicinal herbs useful to mankind. 
ACUTE RENAL FAILURE 
[6, 7, 8]
                                                 
DEFINITON: 
 Acute renal failure is characterized by a rapid decline in glomerular filteration 
rate over hours to days. 
EPIDEMIOLOGY: 
                    Acute renal failure complicates 5-7% of hospital admissions and upto 30% 
of admissions in intensive care units. 
CAUSES: 
              (1) Prerenal ARF (Acute Renal Failure) 
 Hypovolemia 
 Altered renal hemodynamics resulting in hypertension. 
              (2). Intrinsic ARF: 
 Renovascular Obstruction 
 Diseases of the glomeruli (or) vasculature 
 Acute tubular Necrosis 
                            (i) Ischemia 
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                            (ii) Infection 
                            (iii) Toxins 
              It has two types, 
          1. Exogenous:  
 Radio contrast, 
 Calcineurin inhibitors, 
 Antibiotics, 
 Chemotherapy ( eg. Cisplatin) 
 Antifungals, 
 Ethylene glycol. 
2.  Endogenous: 
 Hemolysis, 
 Interstitial nephritis 
 Intratubular Obstruction 
(3)Postrenal ARF ( obstruction) 
(a) Ureteric 
(b) Bladder neck 
(c) Urethra 
TREATMENT: 
Pre-renal ARF    _               Isotonic Saline,Hypotonic Saline 
Intrinsic ARF      _             Glucocorticoids, Alkylating agents 
Post-renal ARF   _             Placement of bladder catheter,  Ureteric Stent Insertion. 
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DRUG INDUCED RENAL DAMAGE: 
                   Drugs can cause impairment of renal function directly by renal damage (or) 
changes in the renal functions (or) indirectly via on blood supply. 
ADVERSE EFFECTS OF DRUGS ON THE KIDNEY: 
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Drugs which are predominantly eliminated by the kidneys and have a narrow 
safety margin are likely to create problems. 
TYPES OF DRUG INDUCED RENAL DAMAGE: 
(1) Direct Renal Damage 
Eg: Lithium cause diabetes insipidus by inhibiting anti diuretic hormone on the 
collecting ducts. 
(2) Indirect damage via effects on blood supply 
Eg: Penicillins and sulfonamides cause vasculitis through hypersensitivity. 
E-amino caproicacid cause vascular thrombosis through which produce renal 
insufficiency. 
Drugs that causes intravascular hemolysis (quinidine,Dapsone)can cause 
hemoglobinuria which cause renal insufficiency. 
TREATMENT 
Elimination of Nephrotoxic agents 
HERBAL DRUGS POSSESS NEPHROPROTECTIVE ACTIVITY 
 
 
 
 
 
BIOLOGICAL SOURCE FAMILY 
Pongamia pinnata Fabaceae 
Crataeva nurvala Capparidaceae 
Ocimum sanctum Labiatae 
Eugenia jambolana Myrtaceae 
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 UROLITHIASIS: 
Nephrolithiais term indicates that the disease is characterized by the formation of 
stone in the kidneys or urinary tract
.[9]
 
Epidemiology: 
Nearly 4-15%of the human populations are suffering from urinary stone problem 
in all over the globe. In the United states 13% of men and 75 of women will develop 
kidney stone during their life time. The area of high incidence of urinary calculi are 
British islands, Scandinavian countries, Central Europe, Northen Australia, Northen 
India, Pakistan, Medditerranean countries. So they are Known as Stone belts. 
[6, 10]
 
MODE OF FORMATION[] 
Excretion of stone substances (Eg:oxalate)+Calcium 
 
Supersaturated solution of salt 
Bacteria (Eg: nano bacteria)                        Lack of substances keeping calcium salts in 
solution 
                                                                        (Magnesium, phosphate) 
                                Lack of inhibitors of crystal formation. 
Citrate, inorganic pyrophosphate and few 
uroepithelial glycoproteins 
Inhibiting nidus of calcium   
Precipitation and salt formation 
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PRE DISPOSING FACTORS 
Urinary pH 
Dehydration- causes increased urinary concentration. 
Stasis- obstruction to urine flow encourages salt precipitation 
Renal disease 
Metabolic factors- Hyper calcuria, hyper phosphaturia, oxaluria, urate excess 
EFFECT AND COMPLICATION: 
Passage of small size stone         Colic 
 
Injury to ureter 
 
    Stricture 
 
Subsequent impaction of stone 
Passage of larger stone  Impaction at upper and lower ends of ureter 
or at brim of pelvi 
  Stasis 
                                                            
    Hydronephrosis          Infection 
            
Staghorn  calculus (Suppuration and 
ulceration of pelvis and calculus leads to 
squamous metaplasia) 
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TYPES:
 [12]
 
1. Calcium stones: 
Calcium oxalate (50%) 
Calcium phosphate (5%) 
Mixture of calcium oxalate and calcium phosphate (45%) 
2. Mixed (struvite) stones  
Magnesium-ammonium-calcium phosphate 
3. Uric acid stone (5-10%) 
4.  Cystine stones (1%) 
5. Hereditary xanthinuria, xanthine stones. 
TREATMENT:
 [6]
 
 Calcium stones are treated with Thiazide diuretics and allopurinol. 
 Antimicrobial agents,Judicious surgery are used for the treatment of struvite 
stones. 
 Alkali and allopurinol are useful in uricacid stones. 
 Cysine stones are treated with allopurinol and penicillamine. 
Herbal drugs used for the treatment of Urolithiasis: 
BIOLOGICAL SOURCE FAMILY 
Coleus aromaticus Labiatae 
Cucurbita pepo Cucurbitaceae 
Mallotus philippensis Euphorbiaceae 
Tribulus terrestris Zygophyllaceae 
Bergenia ligulata Saxifragaceae 
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URINARY TRACT INFECTIONS
[13]
 
Definition 
Urinary tract infection is defined as a disease caused by microbial invasion of  the 
genito urinary tract that extends from the renal cortex of the kidney to the urethral 
meatus. 
PREDISPOSING FACTORS: 
 Gender-Females are more frequently affected by UTI 
 Pregnancy 
 Obstruction to flow of urine(stone,stricture,prostatic hypertrophy and tumour) 
 Neurogenic bladder dysfunction(spinal cord injury,Multiple sclerosis) 
 Bacterial virulence 
 Reflux of urine from bladder up into ureters and sometimes into renal pelvis 
 Genetic factors 
CAUSATIVE ORGANISMS: 
1. Gram negative bacilli: 
Ecoli(70-80%cases), Klebsiella spp, Proteus spp; Pseudomonas aeruginosa, 
Enterobactor , Serratia. 
2. Gram positive bacilli 
Staph.saprophyticus, staph.aures, Staph.epidermidis, Enterococci 
3. Micellaneous 
M.Tuberculosis,Str.pyogens,Str.agalactiae,Citobactor,Salmonella,Gardnerella 
vaginalis 
4. Fungus 
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TYPE: 
Lower UTI 
It includes Urethrits, cystitis, prostatitis 
Upper UTI  
It includes Acute pyelitis, Acute Pyelonephritis 
TREATMENT 
The following drugs are used for the treatment of urinary tract infections 
Quinolone, Nitrofurantoin, Amoxycillin, Ceftriaxone and Gentamicin 
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CHAPTER II 
ETHNO MEDICAL INFORMATION 
All parts of this shrub are used in various indigenous system of medicine for the 
treatment of several diseases. 
Plant is used in the treatment of dysuria and spider bite poisoning. It is also  
useful in abortion and easy delivery.
[14]
 
 Leaves are used to treat chest pain, dysuria ,urinary disorders and kidney 
diseases
[15]
 
 Decoction of the bark is used in anemia, general debility and malnutrition[16]. 
 Fruits are extensively used as an antidote for high coloured urine and as diuretics 
[17]
. 
 Flowers are pounded with milk to treat whooping cough and pulmonary troubles. 
 Roots have been useful for females in white discharge .It also used for urinary 
diseases and as diuretics
[18, 19]
. 
 Aerial parts of the plant are used as antiviral, hypotensive and spasmolytic. 
 Wood is used for torches , fuel and lighting. 
Root, leaf and Stem are used to treat scabies, leprosy, pus formation and eczema. It is 
also used to treat dysuria and spider bite poisoning
[20]
. 
Root, stem and bark were crushed with garlic and the filterate was administered 2-3 
spoons twice dily for five days for chest pain
[21]
. 
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REVIEW OF LITERATURE 
PHARMACOGNOSY 
 Saxena. M.C., and Chawla. A. et al (1985) reported that the Ixora arborea possess 
C4 photosynthetic pathway 
[22]
. 
 Umapathi. P et al,(1979) study reveals that the herbicidal influence on the leakage 
of electrolytes from the leaves of Ixora arborea
[23]
. 
 Rao JVS, et al (1981) screened the physiological studies of Ixora arborea[24]. 
 Bhuyan. D.K. et al (1994) documented fifteen plants used by the tribal people in 
Lohit district of Arunachal Pradesh for abortion and easy delivery
[25]
. 
 Anand, S.P.; and Jeyachandran, R. et al (2008) studied the ethnomedical 
importance of Ixora arborea 
[26]
. 
 Khan SS, et al (1984) reported the folklore uses of Ixora parviflora [27]. 
 Mehta, P.M. et al (1999) studied the effect of mineral salts and growth regulatory 
substances on some biochemical changes during senescence in Ixora and vinca 
flowers
[28]
. 
 Dhivahara, V. et al (2008) reported that the medicinal plants used as home 
remedy
[29]
 . 
PHARMACOLOGY 
 Srinivas, K1, Celestin Baboo R.U
2   
et al (2011) reported that the antiulcer activity 
of flowers of Ixora pavetta against aspirin-induced and pylorus ligation induced 
ulcer in  rat model 
[30]
. 
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 Suvarna, V. and Patil, S. et al (2009) studied the antifungal activity of Ixora 
parviflora against Candida albicans and Aspergillus niger by cup plate method 
[31]
. 
 Serrame, E. et al (1995) documented that the decoction and expressed juice from 
Ixora coccinea having antitumour activity that was 67% in skin tumour, 50% in 
liver tumour and 33% in colon tumour
[32]
. 
 Latha, P.G. ; and Panikkar , K.R. et al (1994) isolated the active principle from 
Ixora coccinea flowers and screened against  ascitic tumours in Swiss albino mice 
at the dose of 100 mg/kg body weight 
[33]
. 
 Latha, P.G. ; and Panikkar , K.R. et al (1999) isolated Ursoli acid from Ixora 
coccinea flowers and evaluated the chemoprotective  effect on cyclophosphamide 
induced toxicity in mice 
[34]
. 
 Latha, P.G. ; and Panikkar , K.R. et al (2001) studied the chemoprotective effect 
of active fraction of Ixora coccinea flowers on cisplatin induced toxicity in mice 
[35]
. 
 Menon, T. V, et al (1980) reported that the pama (scabies) with secondary 
infection was treated with Aragwatha kwatham and pamari ointment containing 
Ixora coccinea
[36]
 
 Nayak, B.S ; et al (1999) screened the effect of Ixora coccinea flowers on dead 
space wound healing in rats 
[37]
. 
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 Saha, M.R., et al (2008) studied the invitro free radical scavenging activity of 
Ixora coccinea by DPPH free radical scavenging assay, reducing power  and total 
antioxidant capacity using Phosphomolybdenum method 
[38]
. 
 Panikkar , K.R. et al (1986) screened the antitumour activity of ayurvedic oil 
preparation containing flowers of Ixora coccinea and Costus sativum in 
preventing the development of Dalton’s Lymphoma and also retard the already 
formed tumour.
 [39]
 
 Nair, S. C., et al (1991) studied the potential antitumour activity of Ixora javanica 
leaves extract against Myelogenious leukemia cells 
[40]
. 
 Pillai,R. R* et al  (1990) reported the alcoholic root extract of Ixora coccinea 
possess anti-inflammatory, antibacterial, antifungal, CNS activity
[41]
. 
 Sadeghai – Nejad,  B., et al (2007) studied the invitro antifungal activity of 
Ixora brachiata leaves and root extracts against microsporum, trichophyton and 
Epidermophyton by agar dilution method
[42]
. 
 Jachariah, R. et al (1994) isolated and evaluated the anti-inflammatory and 
antimitotic effect of Lupeol from the petroleum ether fraction of ethanolic extract 
of leaves of Ixora coccinea 
[43]
. 
 Kumar, S. R, et al (2009) studied the anthelmintic activity of methonolic extract 
of flower of Ixora coccinea against Indian earthworm pheretima posthuma in 0.1, 
0.5, and 1% w/v concentration 
[44]
. 
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PHYTOCHEMISTRY 
 Chauhan J S, et al (1984) reported that the New flavones glycoside isolated from 
the stem of Ixora araborea has been characterized as chrysin 5-o-beta-D-xylo 
pyranoside 
[45]
. 
 Daulatabad C D, et al (1982) studied the seed oils of Ixora parviflora contain 
lauric acid  (3.1% wt), capric acid (1.3 % wt), myristic (4.7 % wt), palmitic 
(11.4% wt), stearic (11.9% wt), arachidic (2.9 % wt), behenic (2 % wt), oleic 
(18.7 % wt) and linoleic acid (44 % wt) 
[46]
. 
 Ragasa, C . Y. ; et al (2004) reported the Ixora coccinea have new cycloartenol 
esters, lupeol fatty ester, lupeol, ursolic acid, oleaninc acid and sitosterol 
[47]
. 
 Chauhan, J S . ; et al (1996) isolated and identified the apigenin-4-o-beta-D-
glucopyranodise and a new aliphatic keto alcohol (11-hydroxy-d.dec-5-en-2-one) 
from Ixora finlarysoniana 
[48]
. 
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 CHAPTER III 
 AIM AND SCOPE OF THE STUDY  
Ixora pavetta is a large ever green shrub belonging to the family 
Rubiaceae. 
The ethno medical information revealed that almost all parts of this shrub is 
used in various indigenous system of medicine against several diseases. 
 Leaves are used to treat chest pain, dysuria , urinary disorders and kidney 
diseases. 
 Fruits are extensively used as an antidote for high coloured urine and as diuretics. 
 Roots have been useful for a female in white discharge .It is also used for urinary 
diseases and as diuretics. 
 Aerial parts of this plant is used as antiviral, Hypotensive and spasmolytic. 
 Root, leaf and Stem are used to treat dysuria and spider bite poisoning. 
Phytochemical studies on the stem has been reported for the presence of a flavone 
glycoside and it has been characterized as chrysin 5-o-(beta)-D-xylo pyranoside. 
It has also been reported that the flowers of Ixora pavetta was used to treat ulcer, 
in aspirin induced and pylorus ligation induced rat model. This effect was comparable 
with standard drug omeprazole. 
It has been reported for antifungal activity against candida albicans and 
aspergillus niger. 
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So the present study has been designed to carry out the following work on the 
leaves of Ixora pavetta. 
1) It is planned to carry out the detailed pharmacognostical studies on the leaves of 
this plant. 
2) Preliminary phytochemical studies were carried out for the crude drug as well as 
extracts inorder to confirm the presence of primary and secondary metabolites 
like proteins, flavonoids, tannins, sterols. 
3) Extraction of ethanolic extract of the leaves of Ixora pavetta (EIP) and 
preparation of phenolic rich fraction of this extract(CIP). 
4) To estimate the total phenolic, tannin and flavonoid content in both 
extracts(EIP&CIP). 
5) Phytochemical evaluation of these extracts by means of TLC and HPTLC studies 
6) It is planned to evaluate the extracts of this plant (EIP & CIP) for the following 
pharmacological studies 
(a) Determination of invitro antioxidant potential by 
 DPPH assay 
 Hydrogen peroxide Scavenging activity 
 Nitric oxide scavenging activity 
(b) Evaluation of nephroprotective activity of Ixora pavetta on 
cisplatin induced nephrotoxicity. 
                               (c) Invitro calcium oxalate crystallization inhibition by Ixora pavetta 
                              (d) Antibacterial activity of Ixora pavetta against urinary tract  
           Pathogens. 
Pharmacognostical Studies 
 
Department of Pharmacognosy, MMC, Madurai  18 
 
CHAPTER IV 
PHARMACOGNOSTICAL STUDIES 
Ixora pavetta is a large evergreen  shrub belonging to the family Rubiaceae. 
SECTION A 
SYSTEMATIC POSITION 
[49]
: 
Kingdom                        :     Plantae-plants 
Subkingdom                   :     Tracheobionta-vascular plants 
Super division                :       Spermatophyto-seed plants 
Division                         :        Magnoliophyta-flowering plants 
Class                              :         Magnoliopsida-dicotylidons 
Subclass                         :        Asteridae 
Order                              :       Rubiales 
Family                            :     Rubiaceae 
Genus                              :          Ixora 
Species                            :        pavetta 
SYNONYM: 
               Ixora parviflora,Ixora arborea,Ixora decipens 
COMMEN NAME: 
               Small flowed Ixora,Torch tree 
VERNACULAR NAME 
[17]
: 
English: Torch tree, Torch wood ixora 
Hindi: Kotagandhal, Nevari 
Kanada: Grorabikattige, Kansuragi 
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Malayalam: Sujimulla 
Sanskrit: Iswara, Nevali 
Tamil: Shulundu-kora, Korivi 
Telugu: Korivipala, puttupala, Kachipadel, Gorivi 
GEOGRAPHICAL DISTRIBUTION: 
It is found in Assam, Kerala, Nicobar islands, Bangladesh, Ceylon and Pakistan. 
HABIT AND HABITAT OF PLANT 
[17, 50, 51]
: 
A large evergreen shrub with white flowers. Bark is dark brown , wood bears light 
reddish brown .The green branches are said to be used for torches. 
DESCRIPTION OF THE PLANT: 
LEAVES 
Arrangement: opposite 
Type: simple, subsessile. 
Margin: Entire 
Shape: Ovate-oblong 
Colour: Dark green 
Size: 3-6 inch long 
Surface: coriaceous 
Apex: obtuse 
Base: Cuneate 
FLOWER 
Colour: white 
Inflorescence: Terminal cyme 
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Odour: Fragrant 
Size: 1/3 inch long 
Shape: lobes oblong 
Margin: Curted 
Flowers are corymbs or panicles at the end of the branches. Sepal tube have a small teeth 
and style protrudes out of the flower with bifurcated stigma. 
FRUIT 
Shape: globose 
Diameter: 0.25 inch 
Colour: black 
SEED 
It appears in plane convex shape. 
WOOD 
It is brown, hard and heavy close grained. It appears smooth and good polish. 
 
 
 
 
 
 
 
 
 
Pharmacognostical Studies 
 
Department of Pharmacognosy, MMC, Madurai  21 
 
SECTION- B 
MIROSCOPICAL STUDIES OF THE LEAVES 
[52, 53 54,55]
 
MATERIALS AND METHODS: 
Fresh leaf was used for the microscopical examination. The cut portion of the leaf 
was fixed using FAA (Formalin 5ml+Acetic Acid 5ml+70%ethanol 90ml).After 24 hrs of 
fixing the specimens were dehydrated with graded series of tertiary butyl alcohol, and 
then the filteration was carried out  by gradual addition of paraffin wax (58-60˚c)Then the 
specimens were cast into paraffin blocks. The paraffin embedded specimens were 
sectioned with the help of Rotary microtome.  The sections were stained with toluidine 
blue. 
ANATOMY OF THE LEAF:  
       The leaf consists of thick midrib which projects more on the abaxial side. The lamina 
is smooth and thick. The lateral veins do not raise above or below the leaf  surface. The 
midrib is slightly raised to short wide abaxial hump; the abaxial part is broadly 
semicircular and thick. The midrib is 1.4mm thick, The adaxial part is 20µm in height 
and 40µm in breath. The abaxial part is 1.2mm wide. 
     The midrib consists of a thick epidermal layer of semi circular cells and thick cuticle. 
The ground tissue is parenchymatous, circular thick walled and compact dark tannin 
content occurs in many of the parenchyma cells, especially in those cells which are 
adjoining the vascular cylinder. (Fig.2.1) 
                       The vascular system consists of a wide outer cylinder and narrow central 
cylinder (Fig.2.2). The outer cylinder is plano convex in sectional view with semicircular 
lower part and flat plate of upper part.  
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The xylem part of the cylinder consists of outer thin zone of fibres and inner short 
radial parellal rows of xylem elements.  The xylem elements are narrow, thin walled and 
circular phloem encircles the xylem cylinder forming thick continous cylinder of small 
cells. 
Within the outer cylinder occurs a narrow, horizontally elliptical small hollow 
cylinder of xylem with central phloem.(fig.).   The xylem elements are mostly fibers. 
LAMINA (Fig 3.1) The lamina is 170 µm thick and the cells are wide and squarish in 
outline.  It is 25µm thick.  The abaxial epidermis is comparatively thin.  The cells are 
rectangular or cylindrical and are 15 µm thick.  The mesophyll tissue consists of upper 
wide zone of three layers of short, compact cylindrical palisade cells.  The lower part 
consists of about 6 layers of loosely arranged spherical or lobed spongy mesophyll. 
LEAF – MARGIN (Fig 3.2) :  The marginal parts of the leaf is gradually taperring into 
slightly bent down tip.  The structure of the leaf margin is not much different from 
middle part of the lamina.  The epidermal cuticle is more prominent.  The palisade-
spongy tissues are distinct.  Prominent circular vascular strands are seen in the marginal 
part.   They do not project beyond the levels of the surface.  The margin is 200 µm thick.  
PETIOLE (Fig 4.1,2;5.1,2) :  The petiole is squarish cross sectional view with two 
prominent adaxial lateral wings.  It is 1.5 mm in both vertical and horizontal planes.  The 
petiole consists of a prominent epidermal layer, parenchymatous ground tissue and a 
closed hollow vascular cylinder. 
 The epidermal layer is thick comprising wide squarish cells and thick cuticle. The 
ground tissue consists of fairly thick walled compact parenchyma cells.  The vascular 
system includes a main, central circular hollow cylindrical and one ortho small circular, 
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solid wing bundles.  The main cylinder comprises several long, uniseriate parallel radial 
lines of xylem elements surrounded externally by thin layer of phloem.  In the central 
core occurs tannin containing parenchyma cells.  The vascular cylinder is 850 µm in 
diameter. 
 The wing part is thick and conical; it iis 300 µm long and 200 µm thick.  The 
epidermal layer of wing is thin with thick  cuticle.  The ground tissue is parenchymatous 
and compact embedded in the wing are one or two circular vascular strands.  The wing 
traces are circular with radiating files of xylem elements surrounded external layer of 
phloem. 
CRYSTAL DISTRIBUTION:  Calcium oxalate crystals are abundant in leaf and petiole.  
In the petiole, the crystals are prismatic type and are located in the phloem parenchyma 
(Fig 6.1).   
 In the leaf, crystals druses (sphaerocrystals).  They occur in the palisade and 
spongy mesophyll tissues.  The druses are located in dilated circular specialized cells 
called Idioblasts (Fig 7.1,2).  The crystal bearing idioblasts are random in distribution. 
STOMATA (Fig 8.1,2) :  The leaf is hypostomatic.  The stomata are predominantly 
paracytic type.  The two subsidiary cells are equal in size.  The guard cells are broadly 
elliptical measuring 50 X 100 µm.  The epidermal cells are polygonal with fairly thick 
straight anticlinal walls. 
 The epidermal cells along the costal region are vertically elongated and are 
parallel to each other.  Their walls are comparatively thick.  No stomata are seen on the 
costal region (Fig 9.1,2). 
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VENATION :  The venation is reticulate with dense thick veins and veinlets (Fig 10.1,2).  
The veins of different orders are different in thickness.  The vein islets are fairly distinct 
with boundaries of thick veins.  The islets are variable in size and shape.  The vein 
terminations are thick and are straight or curved.  (Fig 10.2).  
EPIDERMAL CELLS:  small pieces of epidermis are often seen in the powder of the 
leaf. The adaxial epidermis is apostomatic. The cells are 4-6 sided, the walls are thick, 
prominent parallel plates of cuticular striations are seen on the periclinal walls of the cells 
(Fig 11.1,2) . Peeling of the abaxial epidermis are also common in the powder (Fig 
12.1,2). The abaxial epidermis is densely stomatiferous. The stomata are paracytic type 
with more or less equal subsidiary cells lying parallel on either side of Guard cells. The 
periclinal walls exhibit thick cuticular plates in dense parallel lines(Fig 12.2). 
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SECTION C 
                                                POWDER MICROSCOPY 
ORGANOLEPTIC CHARACTERS: 
Nature  :  Coarse 
Colour    :  Green 
Odour   :  Characteristic 
Taste     :  Bitter followed by astringent taste. 
Powder microscopy of the leaves shows  the following characters, 
 Epidermal cells with paracytic stomata. 
 Fragment of leaf showing prismatic and druses of calcium oxalate crystals in 
abundance. 
 Parenchyma cells containing tannin are present. 
 Presence of polygonal epidermal cells with thick anticlinal walls. 
 Fragment of leaf showing lignified annular xylem vessel 
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SECTION-D 
QUANTITATIVE MICROSCOPY 
DETERMINATION OF LEAF CONSTANTS: 
[56, 57]
 
  The vein islet number, vein termination number, stomatal number and stomatal 
index were determined on fresh leaves using standard procedure. 
VEIN ISLET NUMBER AND VEIN TERMINATION NUMBER: 
The term vein islet is used to denote the minute area of photo synthetic tissue 
encircled by the ultimate division of the conducting strands. The number of vein islets per 
square mm area is called vein- islet number. 
Vein termination number may be defined as the number of vein terminations present in 
one square mm area of the photosynthetic tissue. 
[67]
 
Determination of vein islet number and vein termination number: 
Pieces of leaves were cut from various regions of the leaves between midrib and 
the margin, cleared in chloral hydrate and mounted on a slide.   
Camera Lucida and drawing board were arranged.  With the help of a stage micrometer, 
camera Lucida and microscope, 1mm square was drawn on the paper.  Then the stage 
micrometer was replaced by the preparation and the veins were traced in that square.  
Then the vein islets and vein terminations were counted in the square.  Ten such readings 
were taken and the average was calculated and the results were presented in   
[67,68] 
Table-1. 
STOMATAL NUMBER: 
The average number of stomata per square mm area of epidermis of the leaf is 
called stomatal number. 
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Determination of Stomatal Number: 
Pieces of upper and lower epidermal peelings were mounted on a slide with the 
help of camera Lucida and stage micrometer 1 mm square was drawn on a paper.  The 
stage micrometer was replaced by the preparation.  Then the preparation was observed 
and the stomata marked in that unit area.  Number of stomata present in those unit area 
was calculated.  Ten such readings were taken and the average of stomatal number was 
calculated.
[67]
 
STOMATAL INDEX:  
Definition: 
   It is the percentage which the numbers of stomata form to the total number 
of epidermal cells, each stoma beings counted as one cell.  
Stomatal index        S.I =
 
   
 ×100 
Where, S=number of stomata per unit area 
           E= number of epidermal cells in the same unit area 
Determination of Stomatal Index: 
       The procedure adopted in the determination of stomatal number was followed and 
then the preparation was observed under high power.  The epidermal cells and the 
stomata were counted.  From these values the stomatal index was calculated using the 
above formula 
[68].
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SECTION E 
The physical parameters such as total ash, Acid insoluble ash, Water soluble ash, 
Water insoluble ash, Extractive values and Loss on drying were determined separately for 
air dried powdered leaves of this plant as per standard method. 
PHYSICAL PARAMETERS 
POWDER ANALYSIS 
[58, 59]
 
The behaviour of the powder with different chemical reagents was carried out as 
mentioned by Kay (1938) and Johansen (1940) 
[40, 43]
. The observations are presented in 
Table 2 
FLUORESCENCE ANALYSIS 
[60]
 
The fluorescent analysis of the drug powder as well as the plant extracts of Ixora 
pavetta were carried out by using the method of Chase and Pratt (1949) 
[44]
. The 
observations are tabulated in Tables 3 and 4. 
Determination of Volatile Oil 
[61]
                      
Volatile oils are characterized by their odor, oil like appearance and also it has 
ability to volatilize at room temperature. Chemically they are mixtures of monoterpenes, 
sesquiterpenes and their oxygenated derivatives. Volatile oils can be estimated by hydro 
distillation method by standard procedure. 
The result is presented in Table 5. 
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Determination of foreign organic matter
[62]
 
The part of organ or organs other than those specified in the definition or 
description of the crude drugs is defined as foreign organic matter. An accurately 
weighed 100g of air dried coarse drug and spread out in a thin layer.  
The sample drug was inspected with the unaided eye or with the use of 6X lens 
and the foreign organic matter was separated manually as completely as possible and 
weighed. The percentage of foreign organic matter was calculated with reference to the 
weight of the drug taken. The result is presented in Table 5. 
Determination of Moisture Content (Loss on Drying) 
[61, 62]
 
An accurately weighed 10g of coarsely powdered drug was placed in a tared 
evaporating dish. Then the dish was dried at 105
o
C for 5h and weighed. The drying and 
weighing was continued at one hour intervals until the difference between the two 
successive weighing is not more than 0.25%. The loss on drying was calculated with 
reference to the amount of powder taken. The readings are tabulated in Table 5 
ASH VALUES:
 [63, 64]
 
  The ash values were determined by using air dried powdered leaves as per the 
official method. 
(A) Total ash: 
   2 grams of the crude leaf powder was accurately weighed in a tarred nickel 
crucible. The ground drug was scattered in a fine even layer on the bottom of the crucible 
and incinerated by gradually increasing the heat not exceeding 450˚ c [dull red heat] until 
free form carbon. Then it was cooled and weighed for constant weight. The percentage of 
ash with reference to the air dried drug was calculated. 
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(B) Acid insoluble ash: 
The ash obtained in (A) was boiled for 5 minutes with 25ml of 2M hydrochloric 
acid. The insoluble matter was collected in a tarred sintered glass crucible. The residue 
was washed with hot water, ignited to constant weight, cooled in a desiccator and 
weighed. The percentage of acid insoluble ash with reference to the air – dried drug was 
calculated. 
(C)  Water soluble ash: 
  For water soluble ash, ash obtained in (A) was boiled with 25ml of distilled water. 
The insoluble matter was collected in a Gooch crucible, washed with hot water ignited to 
a constant weight. Cooled in a desiccator and weighed. The weight of the insoluble 
matter was subtracted from the weight of the total ash. The difference gave the weight of 
the water soluble ash. It was calculated with reference to the air-dried powder. The results 
were represented in Table 5. 
Determination of Extractive values:
 [62,63]
 
I) Petroleum ether soluble extractive value  
                 5 gm of the air –dried drug, coarsely powdered, was macerated in 100ml of 
petroleum ether in a closed flask for 24 hours, shaking frequently during 6 hrs and 
allowed  stand for 18 hrs, filtered rapidly, taking precautions against loss of solvent. 25ml 
of the filtrate was evaporated to dryness in a tarred flat bottomed shallow dish and dried 
at 105˚ c, to constant weight. The percentage of the petroleum ether soluble extractive 
with references to the air - dried drug was calculated as presented in Table 5 
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 II) Alcohol (Ethanol) and 75% Ethanol soluble extractive: 
  10 gm of the air –dried drug, coarsely powdered, was macerated in 100ml of 
ethanol and 100ml 75% ethanol 5gm for each solvent,  in two separate closed flask for 24 
hours, shaking frequently during 6 hrs and allowed  stand for 18 hrs, filtered rapidly, 
taking precautions against loss of solvent. 25ml of the each filtrate was evaporated to 
dryness in a tarred flat bottomed shallow dish and dried at 105˚ c, to constant weight. The 
percentage of alcohol soluble extractive with references to the air - dried drug was 
calculated as presented in Table 5. 
III) Water-Soluble Extractive: 
5 gm of the air dried drug coarsely powdered, was macerated in 100 ml of 
chloroform water in a closed flask for 24 hours, shaking frequently during 6 hours, and 
allowed to stand for 18 hours. Filtered rapidly, taking precautions against loss of solvent. 
25 ml of the filtrate was evaporated to dryness in a tarred-flat-bottomed shallow dish and 
dried at 105˚ C to constant weight. The percentage of water – soluble extractive with 
reference to the air-dried drug was calculated and presented in Table -5. 
IV) Ether soluble Extractive: 
The above mentioned procedure for the determination of petroleum ether soluble 
extractive was followed for the determination of ether soluble extractive also. 
V) Determination of Chloroform, Acetone, Methanol and Hexane soluble 
extractives: 
 The procedure followed for the determination of alcohol soluble extractive value 
was adopted for the determination of Chloroform soluble extractive, acetone soluble 
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extractive, methanol soluble extractive and hexane soluble extractive. Instead of alcohol, 
respective solvents were used for the determination of their extractive values. 
 The percentage of chloroform, acetone, methanol and hexane soluble extractives 
were calculated and presented in Table 5. 
Table 1: Quantitative analytical microscopical  
parameters of the leaf of Ixora pavetta 
 
S. No. 
 
Parameters* Values obtained 
1 
Stomatal number  in lower 
epidermis 
31 ± 1.32 
2 
Stomatal index in lower 
epidermis  
16 ± 0.53 
3 Vein islet number 3±0.44 
4 Vein termination number 12 ± 1.27 
* mean of 6 readings ± SEM 
 
Table 2: Behavior of the Ixora pavetta powder with various chemical reagents 
Powder + Reagents Colour / Precipitate 
Presence of active 
principle 
Picric acid Yellow precipitate Protein present 
Conc. sulfuric acid Reddish brown color Phyto sterols present 
Lieberman Burchard reagent Reddish brown color Phyto sterols present 
Aqueous ferric chloride Greenish black color Tannins present 
Iodine solution Blue color Starch present 
Mayer’s reagent No cream color Absence of alkaloids 
Spot test No stain Fixed oils absent 
Sulfosalicylic acid White precipitate Protein present 
Aq. Sodium hydroxide Yellow color Flavanoids present 
Mg – HCl Magenta color Flavanoids present 
Aq. Lead acetate White precipitate Presence of tannins 
Note :-  Colour reactions are viewed under natural light by naked eye 
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Table 3:  Fluorescence Analysis of powder of Ixora pavetta 
Powder +reagent Day light 
UV light 
(254 nm) 
UV light 
(366 nm) 
Drug powder 
 
Green Green Brown 
Drug powder +aqueous 
1M sodium hydroxide 
Green Green Brown 
Drug powder + 
alcoholic 1M sodium 
hydroxide 
Green Green Brown 
Drug powder + iodine Red Brown Brown 
Drug powder + 10% 
potassium hydroxide 
Yellow Greenish yellow Brown 
Drug powder +  1M 
hydrochloric acid 
Green Green Brown 
Drug powder + glacial 
acetic acid 
Yellow Greenishyellow Brown 
Drug powder + 50% 
sulphuric acid  
Green Green Brown 
Drug powder + 50% 
nitric acid 
Green Green Brown 
Drug powder + 50% 
hydrochloric acid 
Green Green Brown 
Table 4:  Fluorescence Analysis of extracts of Ixora pavetta 
Extracts Consistency 
Colour in Day 
Light 
Colour under UV Lamp 
 360 nm 254nm 
Petroleum extract Semisolid Yellow Orange Yellow 
Ether extract Semisolid Greenish brown Green Greenish 
brown 
Chloroform 
extract 
Semisolid Yellowish brown Orange Yellowish 
brown 
Ethanol extract Semisolid Yellowish green Orange Green 
Methanol extract Semisolid Yellowish green Orange Green 
Aqueous extract Semisolid Brown Green Dark green 
Hexane extract Semisolid Yellow Reddish orange Green 
Acetone Extract Semisolid Yellowish green Orange Green 
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Table 5: Standardization parameters of Ixora pavetta 
S. No Parameters* Values* expressed 
as % 
1 Volatile oil Nil 
2 Foreign organic matter 0.01 ± 0.12 
3 Moisture content 5.83 ± 0.01 
4 Ash values   
 Total ash  7.39 ± 0.42 
 Acid insoluble ash 1.09 ± 0.17 
 Water soluble ash  5.09 ± 0.90 
 Water insoluble ash  2.29 ± 0.90 
5 Extractive Values  
 Petroleum extract 0.58 ± 0.03 
 Ether extract  4.92± 0.02 
 Chloroform extract  1.22± 0.04 
 Ethanol extract 2.12 ±0.03 
 75 % Ethanol extract 6.81 ±0.03 
 Methanol extract 5.25 ± 0.01 
 Aqueous extract  4.8± 0.03 
 Hexane extract 2.26 ± 0.01 
 Acetone Extract      2.18 ± 0.01 
* mean of three readings 
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CHAPTER-V 
PHYTO CHEMICAL STUDIES 
The leaves of Ixora pavetta was collected in an around Madurai and it was 
authenticated by taxonomist. 
The Shadow dried leaves were powered and then subjected to the following 
preliminary phytochemical studies 
SECTION-A 
ORGANOLEPTIC EVALUATION 
Nature - Coarse powder 
Colour -            Dark Yellowish brown 
Odour   - Characteristic odour 
Taste  - Bitter followed by astringent taste 
 The powdered plant material and extracts were subjected to the following 
chemical tests and the results were tabulated. 
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                                                             SECTION-B 
PRELIMINARY PHYTOCHEMICAL SCREENING
 [65, 66, 67, 68]
 
1. TEST FOR STEROLS 
      The powdered leaf was first extracted with petroleum ether and evaporated to a 
residue. Then the residue was dissolved in chloroform and tested for sterols. 
A) SALKOWSKI’S TEST 
A few drops of concentrated sulphuric acid were added to the above solution, shaken 
well and set aside. The lower chloroform layer of the solution turned red in color 
indicating the presence of sterols. 
B) LIEBERMANN – BURCHARD’S TEST 
To the chloroform solution a few drops of acetic anhydride and 1 ml of 
concentrated Sulphuric acid were added through the sides of the test tube and set aside 
for a while. At the junction of two layers a brown ring was formed. The upper layer 
turned green indicating the presence of sterols. 
2. TEST FOR CARBOHYDRATES 
A) MOLISCH’S TEST 
The aqueous extract of the powdered leaf when treated with alcoholic solution of 
α-naphthol in the presence of sulphuric acid gave purple color indicating the presence of 
carbohydrates. 
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B) FEHLING’S TEST 
The aqueous extract of the powdered leaf was treated with Fehling’s solution I 
and II and heated on a boiling water bath for half an hour. Red precipitate was obtained 
indicating the presence of free reducing sugars. 
3. TEST FOR PROTEINS 
A) MILLON’S TEST  
A small quantity of aciduous – alcoholic extract of the powdered drug  was heated 
with Millon’s reagent. White precipitate turned red on heating Indicated the presence of 
proteins.  
B) BIURET TEST  
 To one portion of aciduous – alcoholic extract of the powdered drug one ml of 
10% sodium hydroxide solution was added, followed by this one drop of dilute copper 
sulphate solution was added. Violet color was obtained indicating the presence of 
proteins. 
4. TEST FOR ALKALOIDS 
A)  About 2gm of the powdered material was mixed with 1gm of calcium 
hydroxide and 5ml of water into a smooth paste and set aside for 5 minutes. It was then 
evaporated to dryness in a porcelain dish on a water bath. To this 200ml of chloroform 
was added, mixed well and refluxed for half an hour on a water bath. Then it was 
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filtered and the chloroform was evaporated. To this 5ml of dilute hydrochloric acid was 
added followed by 2ml of each of the following reagents. 
a) Mayer’s Reagent                 _     No   cream precipitate 
b) Dragendorff’s Reagent       _     No orange brown precipitate 
c) Hager’s Reagent                  _     No   Yellow precipitate  
d) Wagner’s Reagent              _       No Reddish brown precipitate 
B) TEST FOR PURINE GROUP (MUREXIDE TEST) 
  The residue obtained after the evaporation of chloroform as described in (a) was 
treated with 1ml of hydrochloric acid in a porcelain dish and 0.1gm of Potassium 
chlorate was added and evaporated to dryness on water bath. Then the residue was 
exposed to the vapour of dilute ammonia solution. No purple Color was obtained 
indicating the absence of purine group of alkaloids. 
5. TEST FOR GLYCOSIDES 
A) BORNTRAGER’S TEST 
            The powdered leaf was boiled with dilute sulphuric acid, filtered and to the 
filtrate, benzene was added and shaken well. The organic layer was separated to which 
ammonia solution was added slowly. 
                No color reaction observed in ammoniacal layer showing the absence of 
Anthraquinone glycosides. 
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 B) MODIFIED BORNTRAGER’S TEST 
              About   0.1g of the powdered drug was boiled for 2minutes with dilute 
hydrochloric acid and few drops of ferric chloride solution, filtered while hot and 
cooled. The filtrate was then extracted with benzene and the benzene layer was 
separated. Equal volume of dilute ammonia solution was added to the Benzene extract. 
                 No pink color was observed in ammoniacal layer showing the absence of 
anthraquinone  glycosides. 
6. TEST FOR CARDIAC GLYCOSIDES (for deoxysugar) 
   A) KELLER KILIANI TEST 
           About 1g of the powdered leaf was boiled with 10ml of 70% alcohol for 2 
minutes, cooled and filtered. To the filtrate 10ml of water and 5 drops of solution of 
leadsubacetate were added and filtered, evaporated to dryness. The residue was 
dissolved in 3 ml of glacial acetic acid. To this 2 drops of ferric chloride solution was 
added. Then 3 ml of concentrated sulphuric acid was added to the sides of the test tube 
carefully and observed. 
               No reddish brown layer was observed indicating the absence of deoxysugars of 
cardiac glycoside 
7. TEST FOR CYANOGENETIC GLYCOSIDES 
               Small quantity of the powder was placed in a stoppered conical flask with just 
sufficient water, to cover it. A sodium picrate paper strip was inserted through the 
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stopper so that it was suspended in the flask and it was set aside for 2 hours in a warm 
place. 
                No brick red color was produced on the    paper indicating the absence of 
Cyanogenetic glycosides. 
8. TEST FOR SAPONINS  
              About 0.5g of the powdered drug was boiled gently for 2 minutes with 20ml of 
water and filtered while hot and allowed to cool. 5 ml of the filtrate was then diluted 
with water and shaken vigorously.  Frothing was produced indicating the presence of 
saponins. 
9. TEST FOR TANNINS  
           A small quantity of the powdered drug was extracted with water. To the aqueous 
extract few drops of ferric chloride solution was added. 
Bluish black color was produced indicating the presence of tannins. 
10. TEST FOR FLAVONOIDS 
 A) MAGNESIUM TURNING- CON HCl TEST 
         A little of the powdered drug was heated with alcohol and filtered. To the test 
solution magnesium turnings and few drops of concentrated hydrochloric acid were 
added. Boiled for five minutes. Red colour was obtained indicating the presence of 
flavonoids. 
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B) ALKALI TEST 
       To the small quantity of test solution 10% aqueous sodium hydroxide Solution was 
added.  Yellow orange color was produced indicating the presence of flavonoids.  
C) ACID TEST 
To the small quantity of test solution, few drops of concentrated Sulphuric acid 
was added. Yellow orange color obtained indicates the presence of flavonoids. 
11. TEST FOR TERPENOIDS 
 A little of the powdered leaf was extracted with chloroform and filtered. The 
filtrate was warmed gently with tin and thionylchloride. Pink color solution appeared 
which indicated the presence of terpenoids. 
12. TEST FOR THE PRESENCE OF VOLATILE OIL 
Weighted quantity (250 gm) of fresh leaves were extracted the subjected to 
hydrodistillation using volatile oil estimation apparatus (BP 1980). 
No volatile oil was obtained indicating the absence of volatile oil. 
13. TEST FOR MUCILAGE  
            Few ml of aqueous extract prepared from the powdered crude drug was  treated 
with ruthenium red. Red color reaction indicating the presence of Mucilage. 
The results were shown in TABLE- 6 and 7 
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TABLE –6 
PRELIMINARY PHYTOCHEMICAL SCREENING FOR THE LEAF POWDER 
OF Ixora pavetta 
S.NO                                TEST RESULTS 
1. TEST FOR STEROLS  
 a. Salkowski’s test + 
 b. Libermann- burchard’s test + 
2. TEST FOR CARBOHYDRATES  
 a. Molisch’s test + 
 b. Fehling’s test + 
 c. Benedict’s test + 
3. TEST FOR PROTEINS  
 a. Millon’s test + 
 b. Biuret test + 
4. TEST FOR ALKALOIDS  
 a. Mayer’s reagent - 
Phyto Chemical Studies 
 
Department of Pharmacognosy, MMC, Madurai  43 
 
 b. Dragendroff’s reagent - 
 c. Hager’s reagent - 
 d. Wagner’s reagent - 
 e. Test for Purine group (Murexide test ) - 
5. TEST FOR GLYCOSIDES  
 a. Anthraquinone glycosides  
     i) Borntrager’s test - 
     ii) Modified Borntrager’s test             + 
 b. Cardiac glycosides  
     i) Keller Killiani test  - 
 c. Cyanogenetic glycosides - 
 d. Coumarin glycosides - 
6. TEST FOR SAPONINS - 
7. TEST FOR TANNINS  
 Fecl3 test  + 
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8. TEST FOR FLAVONOIDS  
 a. Shinoda test + 
 b. Alkali test + 
 c. Acid test + 
9. TEST FOR TERPENOIDS + 
10. TEST FOR VOLATILE OILS - 
11. TEST FOR MUCILAGE  + 
        (+) indicates positive reaction                 (-) indicates negative reaction    
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PRELIMINARY PHYTOCHEMICAL SCREENING FOR THE VARIOUS 
EXTRACTS OF LEAF POWDER OF Ixora pavetta 
Tests 
Pet.ether 
Extract 
Chloroform 
Extract 
Ether 
extract 
Acetone 
Extract 
Methanol 
Extract 
Ethanol 
Extract 
Aqueous 
extract 
Hexane 
extract 
I. Test For Sterols 
Salkowski’
s test 
+ + + + + + - - 
Libermann- 
burchard’s 
test 
+ + + + + + - - 
II. Test for Carbohydrates 
Molisch’s 
test 
- - - - + + + - 
 Fehling’s 
test 
- - - - + + + - 
Benedict’s 
test 
- - - - + + + - 
III.Test for Proteins 
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 Millon’s 
test 
- - - - + + + - 
 Biuret test - - - - + + + - 
IV.Test for Alkaloids 
Mayer’s 
reagent 
- - - - - - - - 
Dragendrof
f’s reagent 
- - - - - - - - 
Hager’s 
reagent 
- - - - - - - - 
Wagner’s 
reagent 
- - - - - - - - 
Test for 
Purine 
group 
(Murexide 
test ) 
- - - - - - - - 
V. Test for Glycosides 
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A) Anthraquinone glycosides 
Borntrager’
s test 
- - - - - - - - 
Modified 
Borntrager’
s test 
- - - - + + + - 
B)Cardiac glycosides 
 Keller 
Killiani test  
- - - - - - - - 
 
Cyanogene
tic 
glycosides 
- - - - - - - - 
 Coumarin 
glycosides 
- - - - - - - - 
VI.Test for 
Saponins 
- - - - + + + - 
VII.Test for Tannins 
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Fecl3 test  - - - + + + + + 
VIII.Test for Flavonoids 
Shinoda 
test 
- - - + + + + - 
Alkali test - - - + + + + - 
Acid test - - - + + + + - 
IX.Test for 
Terpenoid
s 
+ + + + + + - + 
X.Test for 
Volatile 
Oils 
- - - - - - - - 
XI.Test for 
Mucilage  
- - - - + + + - 
      (+) indicates positive reaction                 (-) indicates negative reaction    
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PREPARATION OF EXTRACTS 
The shade dried and coarsely powdered leaves of Ixora pavetta was defatted with 
petroleum ether (60-80˚c)for three days by cold maceration. The defatted marc was 
extracted with 75% ethanol by triple maceration and filtered. The filterate was 
concentrated under reduced pressure to obtain a solid residue which has dark yellowish 
brown in colour. 
ISOLATION OF PHENOLIC RICH FRACTIONS
[69]
 
The ethanolic extract(75%) of Ixora pavetta was fractionated using solvent such 
as hexane, chloroform, ethylacetate, n-butanol. Each fractions were concentrated under 
reduced pressure to get the dry residue. 
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FLOW CHART OF PREPARATION OF PHENLIC RICH FRACTION 
Leaves powder 
                                                                  Extracted with 75%ethanol in water 
75%ethanol Extract 
                                                     Dissolved in Distilled water 
Aqueous and ethanol Extract  
                                                  Extracted with Hexane; thrice 
           
 
Hexane Fraction                         Remaining Extract 
                                                                                                                Extracted with                 
                                                                                                                Chloroform; thrice 
  
                                          Chloroform Fraction                                     Remaining extract 
      Extracted with          
      Ethyl Acetate         
      thrice 
 
                                                    Ethyl Acetate Fraction          Remaining Extract 
                                                                                                                 Extracted with n-  
                                                                                                                 Butanol thrice 
                                                                     n-Butanol Fraction             Remaining Extract 
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SECTION-C 
TOTAL PHENOL DETERMINATION 
[70, 71,72] 
PRINCIPLE 
 Total phenolic content of the various extracts of Ixora pavetta  by Folin Ciocalteu 
reagent method. 
            All the phenolic compounds are oxidised by the Folin-Ciocalteu Reagent. This 
reagent, which is reduced during oxidation of the phenolic substances, into a mixture of 
blue molybdenum and tungsten oxides. 
                  The blue colour produced has a maximum absorption at about 750-760nm. 
The absorption is proportional to the quantity of oxidised phenolic compounds. 
REAGENTS REQUIRED  
a) Folin Ciocalteu Reagent (1N) 
         Commercially available Folin Ciocalteu Reagent (2N) was diluted with an 
equal volume of distilled water. The resultant solution was kept in a brown color 
bottle and stored in refrigerator at 4 ºc. 
b) Sodium carbonate solution (10%) 
c) Standard gallic acid solution. 
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PROCEDURE. 
           To the 1ml (1mg/ml and o.5mg/ml) of various leaf extracts of  Ixora pavetta  
(ehanol and phenolic compound rich fraction of ethanol) 0.5ml of Folin Ciocalteu reagent 
(1N) was added and allowed to stand for 15 mins. Then 1ml of 10% sodium carbonate 
solution was added to the above solution. Finally the mixtures were made upto 10ml with 
distilled water and allowed to stand for 30 minutes at room temperature and total phenols  
were determined by spectrophotometrically at 760nm. 
             The calibration curve was generated by preparing Gallic acid at different 
concentration (2, 4, 6, 8, 10µg/ml). The reaction mixture without sample was used as 
blank. Total phenol content of various leaf extracts are expressed in terms mg of Gallic 
acid equivalent per gm of extract (mg GAE/g) 
 
 
 
 
 
 
 
Phyto Chemical Studies 
 
Department of Pharmacognosy, MMC, Madurai  53 
 
Table-8 
ESTIMATION OF TOTAL PHENOL CONTENT OF Ixora pavetta 
STANDARD 
ABSORBANCE 
TEST 
ABSORBANCE 
TOTAL 
PHENOL 
CONTENT 
sample 
Conc.in 
µg/ml 
Sample 
Conc 
in 
µg/ml 
Mg of 
GAE/gm of 
extract 
Gallic 
acid 
2 
4 
6 
8 
10 
0.148 
0.325 
0.502 
0.813 
0.823 
Ethanol 
 
PHENOLIC 
RICH 
FRACTIONS 
50 
100 
 
 
 
1.60±0.02 
3.01 ±0.005 
 
 
 
277.75±1.60 
260.41±0.81 
 
 
 
Hexane 100 1.79 ±0.040 216.2± 0.25 
Ethyl acetate 100 2.88 ±0.42 321.7± 0.58  
chloroform 100 2.92 ±0.73 329.6 ±0.45 
n-Butanol 100 1.98 ±0.61 237.3 ±0.32 
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Fig-13: Calibration curve of Gallic acid 
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SECTION-D 
TOTAL TANNIN DETERMINATION 
[71, 72]
 
PRINCIPLE  
 Total tannin content of extract was determined by Folin Denis reagent method.                
           Tannin like compounds reduces phosphotungstomolybdic acid in alkaline solution 
to produce a highly coloured blue solution. The intensity of which is proportional to the 
amount of tannins and it was estimated by spectrophotometer at 700nm. 
REAGENTS REQUIRED 
a) Folin Denis Reagent ( sodium tugstate 100g and phospho molybdic acid  20gm 
were dissolved in distilled water 750ml along with phosphoric acid 50ml. The 
mixture was refluxed for 2 hours and volume was made upto 1 litre with distilled 
water )  
b) Sodium carbonate solution (10%) 
c) Standard tannic acid solution. 
PROCEDURE 
           0.2ml of (1mg/ml) leaf extract of Ixora pavetta  was made upto1ml with  distilled 
water . Then add 0.5ml of Folin Denis reagent and allowed to stand for 15 mins, then  
1ml of sodium carbonate solution was added to the mixture and it was  made upto  10ml 
Phyto Chemical Studies 
 
Department of Pharmacognosy, MMC, Madurai  56 
 
with distilled water. The mixture was allowed to stand for 30mins at room temperature 
and the tannin content was determined spectrophotometrically at 700nm.  
The calibration curve was generated by preparing tannic acid at different 
concentration (4, 8, 12, 16, 20µg/ml). The reaction mixture without sample was used as 
blank. The total tannin content in the leaf extract was expressed as milligrams of tannic 
acid equivalent per gm of extract. 
TABLE-9 
ESTIMATION OF TANNIN CONTENT 
STANDARD 
ABSORBANCE 
TEST 
ABSORBANCE 
TOTAL 
TANNIN 
CONTENT 
sample Conc.in 
µg/ml 
Sample Conc in 
µg/ml 
Mg of GAE/gm 
of extract 
Gallic 
acid 
2 
4 
6 
8 
10 
0.148 
0.325 
0.502 
0.813 
0.823 
 
Ethanol 
 
 
50 
 
100 
0.105± 0.006 
 
0.232± 0.003 
 
               Average: 
467.21±0.071 
 
486.36±0.052 
 
476.785 
* mean of three readings ± SEM 
Phyto Chemical Studies 
 
Department of Pharmacognosy, MMC, Madurai  57 
 
 
 
 
Fig-14: Calibration curve for Tannic acid 
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SECTION-E 
                                        TOTAL FLAVONOID DETERMINATION 
[73, 74, 75]
 
PRINCIPLE 
The aluminum chloride colorimetric technique was used for estimation of total 
flavonoid estimation. Aluminum ions form stable complexes with C4 keto group and 
either to C3 or C5 hydroxyl groups of flavones and flavonols in acidic medium. It also 
forms acid labile complexes with ortho hydroxyl groups in the A or B rings of flavanoids 
. These complexes showed a strong absorption at 415nm which is used for the estimation 
of flavanoids.  
REAGENTS REQUIRED 
10% aluminum chloride 
1M potassium acetate 
PROCEDURE 
1mL of Ethanolic extract at concentrations 50µg/mL and 100µg/mL were taken 
and0.1mL of aluminum chloride solution, 0.1mL of potassium acetate solution and 
2.8mL of ethanol were added and the final volume was then made up to 5mL with 
distilled water. After 20min the absorbance was measured at 415nm. A calibration curve 
was constructed by plotting absorbance reading of quercetin at different concentrations. 
The sample without aluminium chloride was used as a blank. The total flavonoid content 
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in the extract was expressed as milligrams of quercetin equivalent per gram of extract and 
the results were tabulated.(Fig.13) 
Table-10 ESTIMATION OF TOTAL FLAVONOID CONTENT OF Ixora pavetta 
S.No. Conc. of 
quercetin 
in µg/mL 
Absorbance 
at 415nm 
Conc. of 
ethanolic 
extract in 
µg/mL 
Absorbance 
at 415nm 
Amt of total 
flavonoid 
content in terms 
mg quercetin 
equivalent/ g of 
extract 
1 20 0.589 ± 0.01 50 0.0383± 0.001 467.21±0.351 
2 40 1.151 ± 0.04 100 0.0896±0.006 486.36 ±0.06 
3 60 1.710 ± 0.09    
4 80 2.390 ± 0.03    
5 100 3.112 ± 0.03    
    Average  24.08 
*mean of three readings ± SEM 
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Fig. 15:  Calibration curve of Quercetin 
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CHROMATOGRAPHY 
Thin layer chromatography [76, 77, 78]  
Thin layer chromatography is the technique used for the separation of the natural 
components .Here the principle is adsorption. Silica gel is used as stationary phase. The 
special advantage of TLC is versality, speed, sensitive. Preliminary phytochemical 
screening of the extract revealed that  the presence of flavonoids, phenols, tannins. Hence 
an attempt has been made to evaluate these extracts by TLC and HPTLC studies. 
Table 11:TLC finger profile of the ethanolic extract and phenolic rich fraction of   
                                                           Ixora pavetta 
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Sample Solvent system Detecting agent No of spots Rf  values 
Ethanolic extract  
 3 0.447 
 0.533 
 0.761 
Phenolic rich Fraction   
Hexane 
Toluene: ethyl 
acetate 
: formic acid  (7 
: 3 : 0.2) 
UV light 
2 0.83 
 0.48 
Ethyl Acetate 
2 0.83 
 0.53 
Chloroform 
5 0.40 
 0.48 
 0.63 
 0.75 
 0.80 
n-Butanol 1 0.67 
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High Performance Thin Layer Chromatography [79] 
              High performance thin layer chromatography, also known under the synonym 
Planar Chromatography, is a modern, powerful, analytical technique with separating 
power, performance and reproducibility superior to classic TLC. Based on the use of high 
performance TLC plates with small particle sizes (3-5 µ) and precise instruments for each 
step of the chromatographic process. 
              HPTLC provides the means not only for flexible screening procedures and 
qualitative analyses but also for demanding quantitative determinations. While traditional 
TLC often relies on visual inspection of the chromatographic plate and its documentation 
by either tracing or photography, HPTLC features have highly sensitive scanning 
densitometry and video technology for rapid chromatogram evaluation and 
documentation. 
               Today most HPTLC instruments are computer controlled and can therefore, 
often dramatically improved reproducibility of the analytical result. At the same time 
HPTLC is still as flexible and user friendly as classic TLC, but provides even greater 
advantages. 
MATERIALS AND METHODS 
EQUIPMENT 
              A Cammag make HPTLC system equipped with a sample applicator Linomat5, 
Twin trough glass chamber (20x10 cm
2
) with SS lid, TLC scanner III, Rota vapour. 
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CHEMICALS AND REAGENTS 
              Toluene, ethylacetate and formic acid analytical grade were used. TLC 
aluminium pre coated plate with silica gel 60 GF 254. (20x10 cm
2
 ; 0.2mm thick)was 
used as stationary phase. 
CHROMATOGRAPHY 
               TLC aluminium pre coated plate with silica gel 60 GF 254 (20x10 cm
2
 ; 0.2mm 
thick ) was  used with  
Toluene : ethyl acetate : formic acid ( 7:3:0.2 ) 
as mobile phase. Ethanolic extract (EIP)and chloroform fraction of ethanolic extract 
(CIP)of sample solution  were applied on plate by using Linomat 5 applicator. Cammag 
Twin trough glass chamber (20x10 cm) with SS lid was used for development of TLC 
plate. The twin trough glass chamber was saturated with mobile phase for 30 minutes. 
TLC plate was developed to 8cm distance above the position of the sample application. 
The plates were removed from the chamber and air dried at room temperature. Plates 
were scanned immediately using Cammag TLC Scanner III at wavelength 366 nm and 
254nm 
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HPTLC PROFILE: 
Instrument used : CAMAG make HPTLC. 
Software  : winCATS 1.4.3 
Sample Applicator : Linomat 5. 
Detection            : @254nm & @366nm in Densitometry TLC Scanner 3 
Sample preparation : The sample was prepared in corresponding solvents  
Stationary Phase : HPTLC plates silica gel 60 F 254. 
Mobile Phase  : Toluene: Ethyl acetate: Formic Acid (7:3:0.2)  
Sample  : Track 1: IP 1, Track 2: IP 2 
Fingerprinting:   3D DISPLAY 
@ 254nm               @366nm 
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Fig : 16 Visualization 
@ 254nm     @366nm 
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PEAK DISPLAY 
@ 254nm 
Track 1      Track 2 
  
@ 366nm 
Track 1   
 
 
Track 2 
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TABLES: 12 
Peak 
@ 254nm 
Track 1 Track 2 
Rf value Area  (AU) Rf value Area  (AU) 
1 0.14 3056.9 0.14 8148.9 
2 0.19 415.3 0.19 811.0 
3 0.25 379.1 0.23 585.4 
4 0.52 972.9 0.52 1414.8 
5 0.75 1077.2 0.72 1025.5 
6 0.94 1220.8 0.84 951.5 
7   0.94 1620.0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Phyto Chemical Studies 
 
Department of Pharmacognosy, MMC, Madurai  69 
 
 
 
 
 
Peak 
@366nm 
Track 1 Track 1 
Rf value Rf value Rf value Rf value 
1 0.13 339.3 0.12 874.1 
2 0.19 3069.3 0.15 243.7 
3 0.52 8146.3 0.19 6884.2 
4 0.63 851.7 0.38 819.1 
5 0.73 1174.3 0.52 12784.1 
6 0.78 1233.1 0.59 379.9 
7 0.90 809.5 0.64 1014.8 
8 0.96 399.7 0.73 1091.5 
9   0.79 1185.5 
10   0.90 820.7 
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CHAPTER-VI 
PHARMACOLOGICAL SCREENING 
SECTION-A 
INVITRO ANTIOXIDANT ACTIVITY OF LEAF EXTRACT OF                              
Ixora pavetta. 
 Naturally there is a dynamic balance between the amount of free radicals 
produced in the body and antioxidants to scavenge or quench them to protect the body 
against deleterious effects. Antioxidants are capable of stabilizing or deactivating free 
radicals or reactive oxygen species before they attack the cells. The amount of 
antioxidant principles present under normal physiological conditions may be insufficient 
to neutralize free radicals generated.  Therefore, it is obvious to enrich our diet with 
antioxidants to protect against harmful diseases. Hence there has been an increased 
interest in the food industry and in preventive medicine in the development of “Natural 
antioxidants” from the plant materials. That’s why plants with antioxidant properties are 
becoming more and more popular all over the world. 
                The causes for many degenerative diseases such as atherosclerosis, cancer, 
cirrhosis and diabetes are the presence of reactive oxygen species 
[80-83]
.  
 Synthetic antioxidants like butylated hydroxyl anisole, BHT, tertiary butylated hydroxyl 
quinine and gallic acid esters are available, they are suspected to be carcinogenic and 
have low solubility 
[84-86]
. Hence strong limitations have been placed on their use and 
there is a necessity to replace them with naturally occurring antioxidants
[87]
.  
            Plants derived antioxidants such as tannins, lignans, stilbenes, coumarins, 
quinones, xanthones, phenolic acids, flavones, flavonols, catechin, anthocyanins  and 
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proanthocyanins could delay or prevent the onset of degenerative diseases because of 
their redox properties which allow them to act as hydrogen donors, reducing agents, 
hydroxyl radicals scavengers and nitric oxide scavengers
[88-89]
.  
Many in vitro models for evaluating antioxidant activity are available. Some of 
them are enumerated below 
1. DPPH method 
2. Superoxide radical scavenging activity 
3. Hydroxyl radical scavenging activity 
4. Nitric oxide radical inhibition assay 
5. Reducing power method 
6. Phosphomolybdenum method 
7. carotene linoleate model 
8. Xanthine oxidase method 
9. Ferric reducing ability of Plasma 
10. Thiobarbituric acid assay etc. 
METHOD 1: FREE RADICAL SCAVENGING ACTIVITY USING DIPHENYL 
PICRYL HYDRAZYL (DPPH) FREE RADICAL 
[90]
 
PRINCIPLE:  
Total antioxidant assays are used to compare the antioxidant activities of different 
molecules.  DPPH is a stable free radical with a distinctive ESR signal.  It is widely 
accepted that DPPH can accept an electron or hydrogen radical to become a stable 
diamagnetic molecule. Due to its odd electron, the ethanol solution of DPPH, which is 
purple in colour shows a strong absorption at 517nm
[91]
. DPPH radicals react with 
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suitable reducing agents and then electrons become paired off and the solution loses 
colour stochiometrically with the number of electrons taken up 
[92]
 
              DPPH
.
  + AH →  DPPH-H  +  A. 
REAGENTS 
0.1mM diphenyl picryl hydrazyl in ethanol 
Ascorbic acid 
PROCEDURE
[93,94]
 
  DPPH stock solution was prepared by 4mg of DPPH in 100mL of ethanol. To the 
1mL of the extract (EIP and CIP) of different concentrations, 4mL of DPPH was added. 
Control without test compound was prepared in an identical manner. In case of blank, 
DPPH was replaced by ethanol. The reaction was allowed to be completed in the dark for 
about 30min. Then the absorbance of test mixtures was measured at 517nm. The 
percentage inhibition was calculated and expressed as percent scavenging of DPPH 
radical. Vitamin C was used as standard. The percentage scavenging was calculated using 
the formula  
% inhibition = [(Control-Test)/Control] X 100 
The concentration of the sample required for 50% reduction in absorbance (IC50) was 
calculated using linear regression analysis. The results obtained are presented in Table 13 
and Fig 17.  
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Table 13: Percentage inhibition of Ethanolic extract of 
Ixora pavetta and standard ascorbic acid against DPPH at 517nm 
S. 
No. 
Conc. 
in 
μg/mL 
Percentage 
inhibition 
by standard 
ascorbic 
acid 
Conc. 
in 
μg/mL 
Percentage 
inhibition by 
Ethanolic 
extract 
Conc. 
in 
μg/mL 
Percentage 
inhibition by 
Choloroform 
fraction of 
Ethanolic extract 
1 20 25.86 ± 5.63 4 13.52± 3.07 2 26.54 ±0.025 
2 40 53.32 ± 4.84 8 33.98± 1.94 4 39.58 ±0.084 
3 60 62.2 ± 7.35 12 56.95 ±1.52 6 76.64± 0.035 
4 80 81.21 ± 5.87 16 64.69± 2.15 8 89.36± 0.024 
 IC50 
45.51 
μg/mL 
IC50 
43.14 μg/mL 
 
IC50 
58.71 μg/mL 
 *mean of three readings ± SEM  
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METHOD 2: NITRIC OXIDE SCAVENGING ACTIVITY ASSAY 
[95, 96]
   
PRINCIPLE 
Nitric oxide scavenging activity was determined according to the method reported 
by Green et al., 1982 [78]. Sodium nitroprusside in aqueous solution at physiological pH 
spontaneously generates nitric oxide, which interact with oxygen to produce nitrite ions, 
which can be determined by the use of the Griess Illosvoy reaction. The nitrite ions 
produced diazotizes sulphanilamide and then the diazonium salt reacts with N,N- 
naphthyl ethylene diamine dihydrochloride to give a pink colour chromophore which 
has a maximum absorption at 546nm.  
REAGENTS 
10mM sodium nitroprusside 
Phosphate buffered saline pH 7.4 
2% sulphanilamide in ortho phosphoric acid 
0.1%  naphthyl ethylene diamine dihydrochloride  
PROCEDURE  
To 1mL of extracts at various concentrations was added to 1ml of sodium 
nitroprusside, 2.5mL phosphate buffered saline pH 7.4 and mixed  then the mixture was 
incubated at 25
o
C for 30min. From the incubated mixture 1.5mL was taken. To it, 1mL 
of sulphanilamide in phosphoric acid and 0.5mbL of naphthyl ethylene diamine 
dihydrochloride were added and the absorbance was measured at 546nm. Sample blank 
was also prepared without reagents. The reaction mixture without sample was used as 
blank. Ascorbic acid was used as a standard.  
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The percentage inhibition of nitric oxide radical generated was calculated using 
the following formula: 
 % inhibition = [(Control-Test)/Control] X 100 
 The IC50 was calculated using linear regression analysis. The results obtained for the 
nitric oxide scavenging activity assay are presented in Table 14 and Fig. 20. 
Table 14: Percentage inhibition of Ethanolic  
extract of Ixora pavetta against nitric oxide at 546nm 
 
S. No. 
Conc. in 
μg/mL 
Percentage 
inhibition by 
standard ascorbic 
acid 
Percentage 
inhibition by 
extract 
1 44.44 55.71 ± 0.45 27.27± 0.151 
2 88.89 58.94 ± 0.38 35.98 ±0.065 
3 133.33 76.61 ± 3.13 56.43 ±0.016 
4 177.78 78.27 ± 2.56 64.62 ±0.003 
5 222.22 80.03 ± 1.97 78.25 ±0.017 
 IC50 84.65μg/mL 129.65 μg/mL 
*mean of three readings ± SEM 
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Fig. 20: Nitric oxide radical scavenging by Ethanolic extract of Ixora pavetta 
 
 
METHOD 3: DETERMINATION OF SCAVENGING ACTIVITY AGAINST 
HYDROGEN PEROXIDE 
[97]
 
PRINCIPLE:  
   The radical scavenging activity against hydrogen peroxide of plant extract was 
determined by using the method of Ruch et al [83]. The principle is based the capacity of 
the extracts to decompose the hydrogen peroxide to water. 
REAGENTS 
6% hydrogen peroxide diluted with water in the ratio of 1:10 
0.1M, pH 7.4 phosphate buffer  
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PROCEDURE 
            To the 1ml of extract at different concentrations were added to 3.8mL of 0.1M 
phosphate buffer solution (pH 7.4) and then mixed with 0.2mL of hydrogen peroxide 
solution. The absorbance of the reaction mixture was measured at 230nm after 10min.  
The reaction mixture without sample was used as blank. Sample blank was also prepared 
without reagents .Ascorbic acid was used as standard. The percentage inhibition of 
hydrogen peroxide was calculated using the formula        
    % inhibition    =   (A control - Asample) / Acontrol X  100  
 The results are presented in the table 
 
Table 15: Percentage inhibition of hydrogen peroxide 
 by Ethanolic extract of Ixora pavetta 
 
S.No. 
Conc. in 
µg/mL 
Percentage inhibition 
Ethanolic extract of 
Ixora pavetta 
Ascorbic acid 
1 20 14.845 ±2.0854 18.81 
2 40 19.84 ±2.336 23.52 
3 60 29.72 ±3.967 47.85 
4 80 67.69 ±3.075 72.18 
5 100 76.8 ±1.659 86.56 
 IC50 59.65 μg/mL 69.24 μg/mL 
*mean of three readings ± SEM 
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Fig. 21: Percentage inhibition of hydrogen peroxide 
 by Ethanolic extract of  Ixora pavetta and ascorbic acid 
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SECTION-B 
NEPHROPROTECTIVE EFFECT OF ETHANOLIC EXTRACT OF LEAVES OF 
Ixora pavetta ON CISPLATIN INDUCED NEPHROTOXICITY 
BACKGROUND: 
In traditional medicine Ixora pavetta leaves, root and fruits are used for treating kidney 
diseases. 
MATERIALS & METHODS: 
ANIMALS: 
Male wistar albino rats (100-200 gms) were used for the study. The rats were kept in 
polyethylene cages and maintained under standard laboratory conditions at 25±2⁰C 
relative humidity of 50±15% and under a 12 hrs light dark cycle throughout the entire 
period of study. Commercial pellet diet (M/S.S.K.M animal feeds) and water were 
provided ad libitum. The animals were acclimatized to these conditions for one week 
before commencing the experiments. Experiments were carried out according to the 
guidelines of the Institutional animal ethics committee. 
CHEMICALS: 
All the chemicals used for the estimation of serum parameters and tissue homogenate 
were analytical grade and obtained from commercial sources. Cisplatin (Cisteen 
10mg/10ml) was procured from local pharmacy shop.  
PLANT EXTRACT: 
Ethanolic  extract of Ixora pavetta (EIP) and phenolic rich fraction of EIP was made into 
a suspension with 1% Carboxy Methyl Cellulose. 
Pharmacological Screening 
 
Department of Pharmacognosy, MMC, Madurai 81 
 
 
EXPERIMENTAL DESIGN 
[98]
: 
Animals were divided into 5 groups of six animals each . Group II, III, IV &V animals 
were received single dose of 4 mg/kg of cisplatin by intraperitonially on the first day  
alone to induce nephrotoxicity. 
GROUP I: This group of animals were served as control which received 1% CMC for 
five consecutive days. 
GROUP II: Rats were subjected to the adminintration of single dose of cisplatin at 4 
mg/kg by i.p route on the first day alone. 
GROUP III: Rats were treated with EIP (50mg/kg/p.o),  6 hrs prior to the administration 
of cisplatin (4 mg/kg/ip) injection on the first day  alone  and remaining  four  days EIP 
(50 mg/kg /p.o)alone has been administered to the animals. 
GROUP IV: Rats were treated with EIP(100 mg/kg/p.o),  6 hrs prior to the 
administration of cisplatin (4 mg/kg/ip) injection on the first day alone and remaining 
four days EIP(100 mg/kg/p.o) alone has been administered to the animals. 
 GROUP V:Rats were treated with phenolic rich fraction of EIP (10mg/kg/p.o CIP), 6 
hrs prior to the administration of cisplatin(4mg/kg/i.p) injection on the first day alone and 
remaining four days phenolic rich fraction of EIP (10mg/kg/p.o) alone has been 
administered to the animals.  
        On the sixth day of the experiment , blood and urine samples were collected from 
rats of all groups for the assessment of renal function by urinary and serum biochemicals 
parameters
[99]
. Finally all the groups of animals were sacrificed as per CPCSEA 
guidelines. 
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ASSESSMENT OF RENAL FUNCTIONS 
[100-106]
:  
(a) Serum parameters: 
(i) Urea level was estimated by Urease enzymatic method. 
(ii) Creatinine level was  measured by alkaline picrate method  
(iii) Uric acid level and Blood Urea Nitrogen were estimated by diacetyl  monoxime  
method . 
(iv) Total protein was estimated by Biuret method . 
(v)Serum sodium and potassium levels were estimated by flame photometry. 
(b) Urine Parameters: 
(i) Creatinine clearance was estimated by alkaline picrate method. 
 And 
(ii) urinary protein was measured by Sulpho salicylic acid method . 
(ii) Urine sodium and potassium levels were estimated  by flame photometry. 
(c)Anti-oxidant enzymes: 
          The tissue samples were weighed and 10% homogenate was prepared by 
0.15MTris-HCl buffer (pH 7.4) and used for the estimation of tissue anti-oxidant 
parameters like  TBARS ,GSH& Proteins . 
Thiobarbituric acid Reactive Substances (TBARS): 
              TBARS was determined by the method described by Rajkumar DV and Rao 
MNA ,et.al., (1993) 
              To 1ml homogenate 2.5ml of 20% TCA was added and centrifuged .The 
supernatant liquid was dissolved in 2.5ml of 0.05M Sulphuric acid and 3.5ml of 
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Thiobarbituric acid and incubated at 37⁰C for 30 mins. Contents were extracted into n-
butanol and the absorbance was measured at 530nm. 
Reduced glutathione: 
Reduced Glutathione was determined by the method Morn et al., (1979) 1 ml of tissue 
homogenate was precipitated with 1 ml of 10 % TCA and the precipitate was removed by 
centrifugation. To 0.5 ml of the supernatant added 2 ml of 0.6 mM 5,5’Dithiobis-2-
nitrobenzoic acid(DTNB) in 0.2 M Sodium phosphate and the total volume was made 
upto 3 ml with 0.2 M Phosphate buffer (pH 8). 
    The absorbance was read out at 412nm. 
 Table 16. 
Effect of Ethanolic leaf extract of Ixora pavetta on tissue biochemical parameters 
 
 
 
 
 
 
 
 
 Values are expressed as mean±SEM; *P<0.001  
When compared with Cisplatin.
TBARS-Thiobarbituric acid reactive substances; GSH-Reduced glutathione 
 
 
Groups 
 
TBARS 
(nmol/mg of protein) 
 
GSH 
(µg/mg of protein) 
Control 13.55 ± 0.69 43.68± 0.71 
Cisplatin 35.23±  1.03 21.98 ±0.77 
EIP(50mg/kg/p.o) 24.47±  0.51* 30.81 ±0.78* 
EIP(100mg/kg/p.o) 19.72±  0.48* 35.46 ±0.52* 
CIP(10mg/kg/p.o) 17.85±  0.52* 39.15 ±0.45* 
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Table-17 
Effect of Ethanolic leaf extract of Ixora pavetta on Urine biochemical parameters  
GROUPS 
CREATININE 
CLEARANCE 
(ml/min) 
TOTAL 
PROTEIN 
(mg/dl) 
SODIUM(mEq/L) 
POTASSIUM 
(mEq/L) 
Control 16.96± 0.65 8.03± 0.70 0.4± 0.03 1.84 ±0.28 
Cisplatin 7.12 ±0.75 15.74 ±0.57 0.88± 0.03 0.86 ±0.05 
EIP(50mg/kg/p.o) 10.16± 0.55* 12.35± 0.52* 0.66 ±0.03* 1.08 ±0.07** 
EIP(100mg/kg/p.o) 12.29± 0.77** 11.59± 0.38** 0.63 ±0.03** 1.34 ±1.77** 
CIP(10mg/kg/p.o) 13.69±0 .84** 10.98± 0.46** 0.55 ±0.02** 1.4 ±0.17** 
Values are expressed as mean ± SEM;  *P<0.01 and **P<0.001 
When compared with Cisplatin.
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Table-18 
Effect of Ethanolic extract of Ixora pavetta on Serum biochemical parameters 
Values are expressed as mean±SEM; *p<0.05,  **p<0.01 and ***p<0.001 
When compared with cisplatin
GROUPS BUN(mg/dl) UREA(mg/dl) 
CREATININE 
(mg/dl) 
TOTAL 
PROTEIN 
(mg/dl) 
URIC ACID 
(mg/dl) 
SODIUM 
(mEq/L) 
POTASSIUM 
(mEq/L) 
Control 
21.47±0.88 50.61± 0.76 0.55±0.29 8.875±0.42 2.12± 0.17 0.46±0.48 5.68±0.48 
Cisplatin 
77.02±1.05 82.25± 0.61 1.18±.01 4.52±0.32 3.67±0.27 0.88±0.55 8.77±0.27 
EIP(50mg/kg/p.o) 
36.39 ±1.12*** 68.63±0.42** 0.70±0.04** 7.15±0.83** 2.75±0.04** 0.66±0.07** 7.12±1.04* 
EIP(100mg/kg/p.o) 
30.78±0.76*** 
61.41± 0 
.60*** 
0.64±0.04*** 7.57±0.29*** 2.50±0.04*** 
0.63±0.20**
* 
6.78±0.83*** 
CIP(10mg/kg/p.o) 
25.73± 0.56*** 58.61±1.35*** 0.61±0.02*** 8.54±0.24*** 2.31±0.025*** 
0.55±0.12**
* 
6.18±1.18*** 
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HISTOPATHOLOGICAL STUDIES: 
         Kidney was removed from the sacrificed animals of all groups which were 
sectioned longitudinally and kept in 10 % neutral formalin solution. These tissues were 
embedded in paraffin wax and stained with hematoxylin and eosin which was observed 
under light microscope.       
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Statistical Analysis 
All the results were expressed as standard error of mean (SEM).  Data of biochemical 
parameters were analyzed by using one way ANOVA.  Tukey-Kramer Multiple 
comparisons test was applied for post-hoc analysis.  A value of P<0.001,P<0.01 and 
P<0.05  were considered to be statistically significant.   
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SECTION-C 
INVITRO-CALCIUM OXALATE CRYSTALLIZATION INHIBITION BY 
ETHANOLIC EXTRACT OF Ixora pavetta 
MATERIALS AND METHODS: 
CHEMICALS: 
10mM  Calcium chloride dihydrate(Cacl₂.2H₂O) 
4mM Sodium oxalate (Na₂C₂O₄) 
0.15M Sodium Chloride (NaCl) 
PLANT EXTRACT: 
 Ethanolic extract of leaves of Ixora pavetta 
            Phenolic rich fraction of EIP 
EXPERIMENTAL DESIGN 
[9,10]
: 
The effect of extract on calcium oxalate crystallization was determined by the 
time course measurement of turibidity changes due to the crystal nucleation and 
aggregation in the calcium chloride dihydrate solution on the addition of 0.15M sodium 
oxalate .The precipitation of calcium oxalate at 37⁰c and pH6.5 has been studied by the 
measurement of turbidity at620nm.A spectrophotometer UV/Visible (Shimadzu 1800) 
was employed to measure the  turbidity of the formation of calcium  oxalate. 
PREPARATION OF CALCIUM CHLORIDE AND SODIUM OXALATE 
SOLUTION: 
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0.15M Sodium chloride solution was prepared by standard procedure.10mM of 
calcium chloride dihydrate and 4mM of sodium oxalate was prepared by 0.15M sodium 
chloride solution as solvent. 
 
STUDY WITHOUT INHIBITOR: 
About 1.5ml of calcium chloride dihydrate was transferred into the cell and the 
blank reading was recorded. Then 1.5ml of sodium oxalate was added to the above 
solution and the absorbance was recorded at 620nm followed by within 10 minutes of the 
addition of this solution. 
STUDY WITH INHIBITOR: 
 Different concentration (i.e 1mg/ml, 2mg/ml, 3mg/ml) of EIP and( 100µg/ml, 
200µg/ml, 300µg/ml)of CIP  was prepared by using 0.15M sodium chloride solution 
A mixture of 1ml of calcium chloride dehydrate and 1ml of plant extract 
(inhibitor solution) were taken in the cell and the blank reading was recorded. About 1ml 
of 4mM sodium oxalate was added to the above solution and the absorbance was 
recorded at 620nm followed by within 10 minutes of the addition of this solution. 
The percentage of the inhibition was calculatd by using the following formula. 
Percentage of inhibition = [1-(Ti/Tc)] X 100 
      Ti – turbidimetric slope with inhibitor 
       Tc - turbidimetric slope without inhibitor 
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Table-19 
Effect of Ethanolic  extract of Ixora pavetta  on calcium oxalate crystallization 
inhibition 
 
CONCENTRATION(mg/ml) 
OF INHIBITOR 
SLOPE %INHIBITION 
0 0.000614 0 
1 0.000266 56.72 
2 0.000103 83.22 
3 0.0000616 89.96 
 
Table-20 Effect of phenolic rich chloroform fraction of ethanolic extract of  
Ixora pavetta 
 
CONCENTRATION(µg/ml) 
OF INHIBITOR 
SLOPE %INHIBITION 
0 0.000614 0 
100 0.00090 73.81 
200 0.000614 85.24 
300 0.0000616 89.98 
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MICROSCOPIC STUDY: 
    A drop of the crystallizable solution as well as a drop of mixture of 
inhibiting solution with crystallizable solution were placed on the microscopic slide and 
the crystals were observed by research microscope .Growth of crystals in different 
stages(t1 and t2) with and without plant extracts were observed using research 
microscope.  Effect of plant extracts on crystallization were noted and the photograph of 
crystallization were given in figure. 
Table-21 
TIME CORRESPONDING TO THE STAGE OF CRYSTALLISATION WITH 
AND WITHOUT INHIBITOR 
NUMBER OF 
PHOTOGRAPHS 
STAGES OF 
CRYSTALLISATION 
CONCENTRATION 
OF INHIBITOR 
TIME(seconds) 
1 Growth 00 20 
2 Aggregation 00 60 
3 Growth 3mg/ml(EIP) 50 
4 Aggregation 3mg/ml(EIP) 120 
5 Growth 300µg/ml(EIP) 50 
6 Aggregation 300µg/ml(EIP) 120 
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IDENTIFICATION TEST FOR CALCIUM OXLATE CRYSTALS: 
(1) A drop of crystallizable solution was mixed with a drop of Hydrochloric acid and 
viewed  under microscope. Solubilisation of crystals were noted. 
(2) A drop of crystallizable solution was taken with drop of acetic acid and viewed under 
microscope. No change was observed in the crystallizable solution. 
(3) Sulphuric acid 50% was added to the crystallizable solution , a gradual separation of 
needle like crystal of calcium oxalate at the site of orginal crystal. 
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SECTION-D 
ANTIBACTERIAL ACTIVITY 
[107-110]
 
The Ethanolic extract of Ixora pavetta(EIP)and its phenoic rich fraction of the 
extract were screened for antibacterial activity. 
Bacteria  
The various organisms used in the present study include Escherichia coli, 
Klebsiella pneumoniae, Pseudomonas aeruginosa and Proteus mirabilis.  
Preparation of media 
Muller Hinton Agar (MH, Hi media) was used. The formula (gm/litre) Beef - 2 g, 
caesin acid hydrolysate 17.5g, starch 1.5g and agar 17 g; pH 7.4 ± 0.2.   
MH agar (38g) was weighed and dissolved in 1000ml of distilled water and 
adjusted to pH 7.3 ± 0.2, sterilized by autoclaving at 121
o
C for 15 minutes at 15psi 
pressure and was used for sensitivity tests. 
Preparation of bacterial cultures 
Few colonies of the bacterial strains selected for study were picked from the agar 
slants and inoculated into 4ml peptone water in a test tube. These tubes were incubated 
for 2-4 hours to produce suspensions. The suspensions were then diluted, if necessary 
with saline to a density visually equivalent to that of standard prepared by adding 0.5ml 
of 1% barium chloride to 99.5ml of 1% sulphuric acid. These suspensions were used for 
seeding the bacteria in the agar media. 
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Preparation of the extracts 
The plant extract was dissolved in DMSO to get a concentration of 10mg/mL. 
Preparation of agar plates 
The media (20mL) was introduced aseptically into sterilized petridishes 
[89]
 and 
the petridishes were swirled until the agar begins to set. 
Disc Diffusion technique  
The pathogenic strains were then seeded on the MH agar media in a petridish by 
streaking the plate with the help of a sterile swab. Care was taken for the even 
distribution of culture all over the plate. The seeded plates were allowed to dry. 
Test Procedure 
The plain sterile discs of 6mm diameter were obtained from Hi Media. The discs 
were then impregnated with different concentrations of the EIP and CIP of Ixora pavetta 
and solvent DMSO. Amiakacin discs were used as a standard. Each disc contained 30g 
of standard and different concentration of extracts and  DMSO discs were then placed on 
the seeded medium plates. The plates were then incubated at 37
o
C for 24h. The results 
were read by the presence or absence of zone of inhibition. The zone of inhibition was 
then measured. The results are tabulated in  
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Table 22: Antibacterial activity of  Ethanolic extract 
 of Ixora pavetta against various microorganisms 
 
S.N
o 
Name of 
the 
organism 
Zone of inhibition ( mm) 
Standard 
Amikacin 
(30µg/disc) 
EIP  CIP 
1 
mg 
2  
mg 
3 
mg 
Standard 
Amikacin 
100
µg 
200  
µg 
300  
µg 
1. Escherichia 
coli 
24 8 12 20 26 6 16 21 
2. Klebsiella 
pneumoniae 
26 - 8 12 25 6 14 18 
3. Proteus 
mirabilis 
24 4 10 18 24 8 15 20 
4. Pseudomon
as 
aeurginosa 
26 - 8 14 26 8 17 22 
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CHAPTER - VII 
RESULTS AND DISCUSSION 
Chapter1: 
   In this chapter a brief introduction was given on acute renal failure, drug 
induced renal damage , Herbal drug possesses nephroprotective activity, nephrolithiasis, 
types of renal stones , Herbal drug used for the treatment of urolithiasis, urinary tract 
infections, causative organisms and treatment were also discussed in this chapter. 
Chapter-II: 
   This part of the study has dealt about the survey of literature. 
Ethnomedical uses pertaining to Ixora pavetta which indicate that the plant is used to 
treat kidney diseases, urinary disorder and chest pain. 
Chapter-III: 
   Aim and scope of the present study has been discussed in this part of the 
study, though the plant has been claimed to treat kidney diseases and urinary disorder so 
far no work has been reported for the above mentioned activities. Already this plant has 
been reported for the presence of flavone glycosides. Hence it is planned to evaluate the 
extract of this plant for in vitro antioxidant, nephroprotective activity, invitro calcium 
oxalate crystallization inhibition and also antibacterial activity against urinary tract 
bacterial pathogens. 
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Chapter-IV: 
PHARMACOGNOSTICAL STUDIES 
 In this chapter an attempt has been made to fix certain pharmacognostical standards 
for the leaves of Ixora pavetta which includes the macroscopical, microscopical, 
quantitative microscopy and physical standards. 
Section A 
   Systematic position, synonym, common name, vernacular name, 
geographical distribution , Habit and habitat of the plant and morphological characters of 
leaves,  flowers, fruits, seed, wood of this plant were described in detail in this chapter. 
Salient features of the macroscopy of leaves were observed such as leaves bears ovate 
oblong shape, coriaceous surface, obtuse apex and cuneate base. 
Section B 
The following salient anatomical features were observed in the transverse section of the 
leaves; 
  Paracytic stomata are present in abaxial epidermis whereas the abaxial epidermis 
is apostomatic. 
 Ground tissue consists of parenchyma cells and many of them containing Tannin 
in these cells. 
 The vascular system consist of wide outer cylinder and narrow inner cylinder.The 
xylem part of the cylinder consist of outer thin zone of fibres and inner short 
radial parallel rows of xylem elements which is encircled by phloem. 
 Calcium oxalate crystals are present as druses in the palisade and spongy 
mesophyll tissues and also in idioblasts. 
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 T.S of petiole exihibited prominent epidermal layer ,parenchymatous ground 
tissueand a closed hollow vascular cylinder. 
 Tannin containing parenchyma cells are present in the central core . 
 Crystals present in the petiole is prismatic type which are located in the phloem 
parenchyma. 
Section c 
 Powder microscopy of the leaves showed the following anatomical characters. 
 Small pieces of epidermis with paracytic stomata. 
 Prismatic and druses of calcium oxalate crystals. 
 Lignified spiral xylem vessels and  fibres  
 Parenchyma cells consist of tannins. 
Section D 
   This part of the study has dealt about the quantitative microcopy such as 
stomatal number, stomatal index, vein islet number and vein termination number were 
determined and the results were tabulated. 
                   Parameters Values  
Stomatal number in lower epidermis 31 ±1.32 
Stomatal index in lower epidermis 16± 0.57 
Vein islet number 3± 0.44 
Vein termination number 12 ±1.27 
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Section E 
   Physical parameters like profile of ash values, loss on drying and various 
extractive values have been determined for this plant and the results are as follows. 
  
Physical parameters of I.Pavetta 
S. No Parameters* Values* expressed as % 
1 Volatile oil Nil 
2 Foreign organic matter 0.01 ± 0.12 
3 Moisture content 
5.83 ± 0.01 
4 Ash values  
 
 Total ash  
7.39 ± 0.42 
 Acid insoluble ash 
1.09 ± 0.17 
 Water soluble ash  
5.09 ± 0.90 
 Water insoluble ash  
2.29 ± 0.90 
5 Extractive Values  
 Petroleum extract 0.58 ± 0.03 
 Ether extract 4.92± 0.02 
 Chloroform extract 1.22± 0.04 
 Ethanol extract 2.12 ±0.03 
 75 % Ethanol extract 6.81 ±0.03 
 Methanol extract 5.25 ± 0.01 
 Aqueous extract 4.8± 0.03 
 Hexane extract 2.26 ± 0.01 
 Acetone Extract  2.18 ± 0.01 
* mean of three readings 
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  Highest extractive value was noted in 75%ethanolic extract (6.81%)and the 
lowest extractive value was observed in chloroform extract(1.22%). 
Chapter V: 
SectionA 
  This part of the study has dealt about the organoleptic evaluation of Ixora pavetta 
which indicates that the powder material is dark yellowish brown in colour, chacteristic 
odour and bitter followed by astringent taste. 
Section B 
  Collection , authentication of the plant material and preliminary phytochemical 
study of the crude drug and various extracts were discussed in this chapter. This study 
indicates the presence of flavanoids, proteins, anthroquinone glycosides, tannins ,sterols 
and terpenoids. Ethanolic extract (75%) has shown the presence of most of the secondary 
and primary metabolites which are reported to possess various pharmacological activities 
. preparation of ethanolic extract (EIA) by triple maceration was discussed in this 
chapter.The EIA also shown highest extractive values when compare to other 
extracts.Hence this extract has been choosen  for phytochemical and pharmacological 
studies. 
 Preparation of phenolicrich extract by fractionation of EIP by hexane, chloroform, 
ethyl acetate and butanol were discussed in this chapter. 
Section C 
  EIP has been evaluated for total flavonoid content(24.08mg/g),total tannin 
content(269.05mg/g) and phenolic content (269.08mg/g).Above mentioned phenolic rich 
fractions were quantified for total phenolic content which revealed that chloroform 
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fraction showed highest phenolic content (329.6mg/g)when compared with 
hexane(216.2mg/g),ethyl acetate(321.7) and butanol (237.3). 
  This study indicate that both EIP and chloroform fractions were enriched with 
phenolic constituents. Hence these extracts were evaluated for phytochemical and 
pharmacological studies. 
 
ESTIMATION OF TOTAL TANNIN AND FLAVONOID  CONTENT OF 
 Ixora pavetta (EIP) 
 
CONCENTRATION 
(100µg/ml) 
 
TOTAL TANNIN 
CONTENT 
(mg/gm of extract) 
TOTAL FLAVONOID 
CONTENT 
(mg/gm of extract) 
50 467.21±0.071 467.21±0.351 
100 486.36±0.052 486.36 ±0.06 
.. 
 
 
 
. 
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ESTIMATION OF TOTAL PHENOL CONTENT OF Ixora pavetta (EIP &CIP) 
TEST 
 
TOTAL PHENOL 
CONTENT 
Sample Conc. in µg/ml Mg of GAE/gm of extract 
Ethanol 
 
RICHFRACTIONS 
Hexane  
Ethyl acetate 
Chloroform. 
n-Butanol 
50 
100 
 
100 
100 
100 
100 
277.75±1.60 
260.41±0.81 
 
216.2± 0.25 
321.7± 0.58  
329.6 ±0.45 
237.3 ±0.32 
 
Section:D 
TLC and HPTLC studies 
   TLC and HPTLC studies of both EIP and phenolic rich extract(CIP) have 
been dealt in this chapter. TLC study revealed that EIP exhibited three spots and 
chloroform fraction of phenolic rich extract(CIP) exhibited five spots. Both ethyl acetate 
and hexane fraction of phenolic rich extract have shown two spots each and butanol 
fraction of phenolic rich extract has shown only one spot. 
   HPTLC chromatogram was recorded for both EIP and CIP .This study 
revealed that EIP exhibited six spots and CIP  shown seven peaks at 254nm.At 366nm 
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EIP has shown eight spots  and CIP exhibited ten peaks. This study also revealed that 
about eight phytoconstituents were found in EIP and ten phytoconstituents were found in 
CIP. 
Chapter-VI 
Section A 
 Invitro radical scavenging activity was determined for both EIP and CIP by DPPH 
assay method. The percentage inhibition of EIP (16 µg/mL) and CIP (8 µg/mL) were 
found to be 64.69% and 89.36% when compared to the standard ascorbic acid (80 
µg/mL). IC 50  value of EIP and CIP were found to be 43.14 µg/mL and 58.71 µg/mL 
respectively when compared to standard ascorbic acid 45.51 µg/mL. This study revealed 
that CIP has exhibited potent radical scavenging activity than the standard ascorbic acid. 
Nitric oxide scavenging activity of EIP (222.22 µg/mL) was found to be 78.25% of 
percentage  inhibition when compared to ascorbic acid  (222.22 µg/mL) 80.03 % . IC 50  
value of EIP was found to be 129.65 µg/mL when compared to standard ascorbic acid 
84.65 µg/mL. This study indicates that the EIP has shown significant nitric oxide 
scavenging activity when compared to standard ascorbic acid. 
 The EIP has also been evaluated for percentage inhibition of hydrogen peroxide. EIP 
at 100 µg/mL has shown 76.8 % of percentage inhibition of hydrogen peroxide when 
compared to the standard ascorbic acid (100 µg/mL) 86.56%. IC 50  value of EIP was 
found to be 59.65 µg/mL when compared to standard ascorbic acid 69.24 µg/mL. This 
study revealed that EIP has exhibited significant hydrogen peroxide scavenging activity 
activity when compared to standard ascorbic acid. 
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Section-B 
   Nephroprotective effect of EIP and CIP were discussed in this chapter. 
This study revealed that nephrotoxicity induced by ciplatin leads to proximal and distal 
tubular necrosis, predominantly in the corticomedullary region and intratubular stripe of 
the outer medulla. 
Functional nephro toxicity indices such as blood urea nitrogen, serum creatinine, 
blood urea, serum uric acid, potassium and urinary sodium and  protein were elevated in 
cisplatin treated animals when compared to control(P<0.001 ). Serum protein, sodium, 
urinary potassium and creatinine clearance were also decreased significantly when 
compared to control (P<0.001). 
At 50 mg/kg/p.o of  EIP treatment ,functional nephro toxicity indices such as 
blood urea nitrogen, serum creatinine, blood urea, serum uric acid, and urinary sodium 
and protein were decreased  when compared to cisplatin treated animals (P<0.01) and  
serum potassium was found to be decreased when compared to cisplatin treated animals 
(P<0.05). Serum protein, sodium, urinary potassium and creatinine clearance were 
elevated significantly when compared to cisplatin treated animals (P<0.01). 
At100 mg/kg/p.o of EIP treatment,  functional nephro toxicity indices such as 
blood urea nitrogen, serum creatinine, blood urea, serum uric acid, potassium and urinary 
sodium, protein were decreased when compared to cisplatin treated animals (P<0.001). 
Serum protein, sodium, urinary potassium and creatinine clearance were elevated 
significantly when compared to cisplatin treated animals (P<0.001). 
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At 10 mg/kg/p.o of CIP treatment,  functional nephro toxicity indices such as 
blood urea nitrogen, serum creatinine, blood urea, serum uric acid, potassium and urinary 
sodium, protein were decreased when compared to cisplatin treated animals (P<0.001  ).    
 . Serum protein sodium, urinary potassium and creatinine clearance were 
elevated significantly when compared to cisplatin treated animals (P<0.001).   
HISTOPATHOLOGICAL CHANGES: 
                     In the control group animals showed normal tubular epithelial cells and 
glomeruli whereas cisplatin treated animals showed glomerular atrophy, infilteration of 
cells, tubular congestion. Rats treated with 50 mg/kg/p.o EIP showed regenerative 
changes in glomeruli and tubules. Rats treated with 100 mg/kg/p.o EIP and 10 mg/kg/p.o 
CIP showed normal renal parenchyma with no significant pathology.    
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 Kidney plays a role in the maintenance of constant volume and composition of 
extracellular fluid by glomerular filtration, tubular reabsorption and tubular secretion. 
Kidney functions can be evaluated by different methods. Male rats are particularly 
suitable for evaluation of tubular lesions because the intra renal enzyme distribution is 
similar to that of man. 
               Cisplatin is a major anti neoplastic drug used in the treatment of solid tumours. 
Its chief dose limiting side effect is nephrotoxicity. 20% of patients develop renal 
dysfunction when treated  with high dose of Cisplatin. Kidney accumulates Cisplatin to a 
greater degree than other organs and it is the major route for its secretion. 
Cisplatin in proximal tubular epithelial cell is about five times of the serum 
concentration. The dispropotinate accumulation of cisplatin in kidney tissue contributes 
to cisplatin induced nephrotoxicity.In the rat cisplatin excretion occurs predominantly by 
glomerular filteration but very less amount by secretion. Cisplatin is accumulated by 
peritubular uptake in both proximal and distal nephrons. 
The mechanism of cisplatin induced nephrotoxicity involved oxidative stress, 
apoptosis, inflammation and fibrogenesis. Highest concentration of cisplatin through 
necrosis of proximal tubules.Lowest concentration through apoptosis induced acute 
tubular injury.ROS are produced by Xanthine-Xanthine oxidase system, Mitochondria 
and NADPH oxidase in the cells. Cisplatin induced the production of ROS through all 
these pathway and produce renal injury because ROS directly act on cell components 
including lipids, proteins and DNA and destroy their structure. 
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           Cisplatin induces glucose-6-phosphate dehydrogenase and hexokinase activity 
through which it produce increased free radicals and decreased anti-oxidant production. 
Mainly superoxide dismutase, GSH, catalase are significantly decreased. O2·( super oxide 
anion), H2O2 (Hydrrogen peroxide)  and OH (Hydroxyl radical) damage the lipid 
components by peroxidation and denature of proteins. Since they are elevated in Cisplatin 
treated kidneys. 
                    The results of this study showed that treatment with EIP and CIP exihibited 
invivo and invitro antioxidant acivity, this may be due to the presence of antioxidant 
phytoconstituents like phenolic compounds. EIP and CIP reduced the extent of Cisplatin 
induced nephrotoxicity is evidenced by the significant reduction in blood urea nitrogen, 
serum creatinine, blood urea, serum uric acid, potassium and urinary sodium and  protein   
and elevate the level of  Serum protein sodium, urinary potassium and creatinine 
clearance. 
                Morphological and physiological studies identified the renal tubule system as 
the site of maximum Cisplatin damage. Therefore protective effect of EIP and CIP would 
be apparent on the tubular system. The histological results revealed that glomerular 
atrophy, infilteration of cells and tubular congestion occur in Cisplatin treated rats. 
However EIP and CIP treatment ameliorates the overt changes induced by Cisplatin. 
       Preliminary phytochemical studies indicates the presence of phenolic constituents 
like tannins, flavonoids and anthraquinone glycosides. This plant has been reported for 
the presence of flavone glycosides chrysin. Estimation of phenolic constituents of EIP 
revealed the higher content of total flavonoids, total phenols and total tannins. CIP also 
showed the higher concentration of total phenols. Both EIP and CIP have exhibited 
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significant invitro anti-oxidant by DPPH, Hydrogen Peroxide and nitric oxide scavenging 
method. Invivo antioxidant action of EIP and CIP were corroborated by the in vivo 
antioxidant activity by elevation of endogenous antioxidant GSH and decreased the 
TBARS (LPO marker compound) in kidney tissue of  both EIP and CIP treated animals. 
                     Invitro antioxidant and nephroprotective activity may be due to the presence 
of phenolic constituents in these extracts. EIP and CIP were rich in flavonoids and 
tannins which have been ascribed for its strong antioxidant properties. It could possibly 
have a renoprotective effect via modulating the antioxidant system. These results 
revealed the beneficial effects of using free radical scavenger in modulating Cisplatin 
induced nephrotoxicity. 
              The mechanism by which EIP and CIP ameliorate Cisplatin toxicity remains to 
be elucidated. It may be due to inhibition of  lipid peroxidation by scavenging free 
radicals and increasing intracellular concentration of Glutathione. 
Section-C 
This study was designed to evaluate the inhibiting potential of EIP and CIP on 
invitro calcium oxalate crystallization. 
TURBIDIMETRIC STUDY: 
The effect of EIP and CIP on various phases of calcium oxalate crystallization 
was determined by time course measurement of turbidity in the calcium chloride solution. 
In this experiment, initial detectable increase in the turbidity after induction of the 
crystallisation with sodium oxalate  was observed .In the control the initial steap rise in 
turbidity in the nucleation phase and attaining maximum, followed by a decrease in the 
aggregation.EIP and CIP inhibited the slope of turbidity in a concentration dependent 
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manner and followed by very slow decrease. Crystallisation by the addition of calcium 
chloride and sodiumoxalate was inhibited by EIP at 1mg/ml, 2mg/ml,3mg/ml were found 
to be 56.72%,83.22%,89.96%.similarly the CIP at the concentration of 100µg/ml,200 
µg/ml and 300 µg/ml inhibit calcium oxalate crystallization at the percentage of 
73.81%,85.24% and 88.48% respectively. 
The concentration of inhibitor (EIP&CIP), turbidimetric slope relating to the 
curves of crystallization with and without inhibitor and percentage of inhibition were 
tabulated. 
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MIROSCOPIC STUDY 
The photographs indicating the different stages of growth of CaOX crystals 
(t1&t2) with and without inhibitor were presented in figures and tables. 
Crystals of calcium oxalate are primary constituent of more than 60% of the 
majority of human kidney stones. In vitro crystallization systems are used for variety of 
purposes in urolithiasis research. Since kidney stone formation is a complex process it 
includes super saturation, nucleation, growth, aggregation and retention within renal 
tubules. Initial events of nucleation of crystals occur in the first few minutes, the graphs 
were replotted within the first three minutes for each concentration of extract as well as 
control. The initial positive slope of the turbidity curve which is mainly due to increase in 
the particle number resulting from crystal nucleation, after a plateau is achieved in this 
negative slope( i.e) a progressive decrease of absorbance reflected from the decrease in 
the particle number due to the crystal aggregation. 
In this study EIP and CIP extract inhibited the nucleation and aggregation of calcium 
oxalate in a concentration dependent manner. Physiological inhibitors of urolithiasis 
found in urine include inorganic (eg:magnesium, pyrophosphate) and organic citrate, uro 
epithelial glycoproteins, prothrombin fragment and glycosaminoglycons. Organic 
compounds adsorb to the surface of crystal and inhibit the crystal nucleation, growth and 
aggregation. To prevent the recurrent stone formation interference with crystal growth 
and aggregation are the possible therapeutic strategy. 
The medicinal plants contain chemical compounds which possess an inhibitor effect in 
the crystallization of calcium oxalate. Calciumoxalate inhibitors prevent crystal growth 
and aggregation by coating the surface of the growing calcium crystals or by complexing 
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with calcium and oxalate. Chemical constituent like higher carboxylic acid like citrate 
chelates calcium and form soluble chelates and excrete through urine. Macromolecule of 
higher molecular weight of plant extract exerts their action similar to natural urinary 
inhibitors. 
Several studies are carried out using microscope to validate the results obtained 
by the turbidimetric method. Microscopic observation revealed the extract visibly reduces 
the size of crystals with significant reduction of crystal number. Flavonoids, tannins, 
anthraquinone glycosides were present in EIP.EIP and CIP showed higher phenolic 
content and phenolic constituents have been reported for of urolithiasis. Hence the 
calcium oxalate crystallization inhibition of EIP and CIP may be due to the presence of 
phenolic compounds present in these extracts. 
Section D 
Ethanolic extract of Ixora pavetta and its chloroform fractions were used in the 
antibacterial studies by disc diffusion method against E.coli, Klebsiella spp, 
Pseudomonas aeruginosa and Proteus spp 
Zone of inhibition of EIP at 6mg against Ecoli (20mm),Klebsiella 
pneumoniae(12mm),Proteus mirabilis (18mm) and Pseudomonas aeroginosa(14mm) 
showed that the extract has exihibited significant antibacterial activity against E.coli, 
Proteus mirabilis when compared to standard amikacin . 
Zone of inhibition of CIP at 300µg against Ecoli(21mm),Klebsiella 
pneumoniae(18mm),Proteus mirabilis (20mm) and Pseudomonas aeroginosa(22mm) 
indicate that the extract has exihibited significant antibacterial activity against all the 
bacterial pathogens when compared to standard amikacin. 
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 Both these extracts have shown significant antibacterial activity against E.coli, 
Klebsiella pneumoniae, Pseudomonas aeruginosa and Proteus mirabilis. But the ethanolic 
extract was less significant when compared the effect with its chloroform fraction. E.coli, 
Klebsiella pneumoniae, Pseudomonas aeruginosa and Proteus mirabilis are the chief 
causative organisms to produce urinary tract infection. Since the EIP and CIP  shown  
significant antibacterial activity and it could be used for the treatment of urinary tract 
infections.Phenolic compounds present in both EIP and CIP may be responsible for the 
antibacterial activity of these extracts. 
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CHAPTER-VIII 
CONCLUSION 
Recently there has been a revival of interest on Medicinal plants. Large number of 
plants are constantly  being screened for their pharmacological value particularly for their 
nephroprotectiveactivity,urolithiasis,antifertility,amoebicidal,antiparkinsonism,cytotoxic,
hypoglycemic, hypotensive and anti inflammatory properties. 
In this view an attempt was made to explore the plant Ixora pavetta. 
This dissertation deals with pharmacognostical ,phytochemical evaluation and 
pharmacological screening of the leaves of Ixora pavetta. 
 Pharmacognostic parameters had been determined for the leaves in order 
to substantiate and identify the plant for future work. 
 Phytochemical evaluation of the plant including preliminary 
phytochemical screening was performed inorder to confirm the presence of 
phytoconstituents like sterols, carbohydrates, proteins, anthraquinone glycoside, 
flavonoids and tannins. 
Total flavanoid (24.08mg/g),total tannin(269.05mg/g) and total phenolic 
(269.08mg/g)contents were determined for the ethanolic extract (75%) of Ixora 
pavetta and phenolic rich extracts were prepared by means of fractionation  which 
revealed that chloroform fraction born highest phenolic content(329.6mg/g) when 
compared to other fractions.TLC and HPTLC chromatogram have been recorded 
for both EIP and CIP. 
 These extracts have also been evaluated for invitro antioxidant activity by 
DPPH assay, Nitric oxide scavenging and Hydrogen peroxide scavenging   
method. 
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 According to ethno medical information, leaves of this plant is used to 
treat kidney diseases, renal stones and urinary disorders. Inorder to confirm these 
ethnomedical claims both EIP and CIP have been evaluated for nephroprotective 
activity against Cisplatin induced nephrotoxicity in rats .This study indicate that 
both EIP(100mg/kg)(p<0.001)and CIP(10mg/kg) (p<0.001)exert significant 
nephroprotective activity.Mode of action behind this activity may be due to the 
antioxidant potential of these extracts which is evidenced by elevation of 
GSH(p<0.001) and reduction of TBARS (p<0.001) in the tissue parameters. 
 These extracts have also exhibited  inhibition of invitro calcium oxalate 
crystallization at 3mg/ml of EIP and 300µg/ml of CIP and phenolic compounds 
may be attributed for this activity.These extracts have also shown significant 
antibacterial activity against E.coli,Klebsiella pneumonia,Proteus mirabilis and 
Pseudomonas aeruginosa at 6mg of EIP and 300µg of CIP. 
 Antibacterial activity may also be due to the presence of phenolic 
constituents present in these extracts. Hence it is suggested that phenolic 
phytoconstituents responsible for both invitro and invivo antioxidant activity, 
nephroprotective activity, invitro urolithiatic activity and antibacterial activity for 
UTI may be isolated and evaluated for further studies. 
These phenolic phytoconstituents may serve as a lead molecule for the 
development of newer drugs to treat various life threatening diseases, such as renal 
failure, renal calculi, diseases caused by oxidative stress and urinary tract infection 
caused by multidrug resistant strains. 
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Fig: 22 Effect of Ixora pavetta on Cisplatin induced histopathological 
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Fig: 23 PHOTOGRAPHS OF CRYSTALLIZATION FOR WITHOUT AND WITH 
INHIBITOR 
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